TWI687370B - Chlorine dioxide producing unit and chlorine dioxide producing apparatus - Google Patents
Chlorine dioxide producing unit and chlorine dioxide producing apparatus Download PDFInfo
- Publication number
- TWI687370B TWI687370B TW105116600A TW105116600A TWI687370B TW I687370 B TWI687370 B TW I687370B TW 105116600 A TW105116600 A TW 105116600A TW 105116600 A TW105116600 A TW 105116600A TW I687370 B TWI687370 B TW I687370B
- Authority
- TW
- Taiwan
- Prior art keywords
- chlorine dioxide
- chlorite
- light
- unit
- light source
- Prior art date
Links
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 title claims abstract description 490
- 239000004155 Chlorine dioxide Substances 0.000 title claims abstract description 245
- 235000019398 chlorine dioxide Nutrition 0.000 title claims abstract description 245
- 229910001919 chlorite Inorganic materials 0.000 claims abstract description 94
- 229910052619 chlorite group Inorganic materials 0.000 claims abstract description 94
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 claims abstract description 93
- 239000007787 solid Substances 0.000 claims abstract description 37
- 239000003814 drug Substances 0.000 claims description 181
- 238000003860 storage Methods 0.000 claims description 80
- 229940079593 drug Drugs 0.000 claims description 76
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 55
- 239000003795 chemical substances by application Substances 0.000 claims description 54
- 239000003054 catalyst Substances 0.000 claims description 49
- 239000000126 substance Substances 0.000 claims description 37
- 229960005196 titanium dioxide Drugs 0.000 claims description 30
- 239000004408 titanium dioxide Substances 0.000 claims description 26
- 229910052751 metal Inorganic materials 0.000 claims description 24
- 239000002184 metal Substances 0.000 claims description 24
- 229910044991 metal oxide Inorganic materials 0.000 claims description 24
- 150000004706 metal oxides Chemical class 0.000 claims description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 239000007864 aqueous solution Substances 0.000 claims description 11
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 239000004113 Sepiolite Substances 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 8
- 229910052624 sepiolite Inorganic materials 0.000 claims description 8
- 235000019355 sepiolite Nutrition 0.000 claims description 8
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical group [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 claims description 8
- 229960002218 sodium chlorite Drugs 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 238000007664 blowing Methods 0.000 claims description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 239000010451 perlite Substances 0.000 claims description 6
- 235000019362 perlite Nutrition 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 5
- 229910021536 Zeolite Inorganic materials 0.000 claims description 5
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000010457 zeolite Substances 0.000 claims description 5
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 4
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 4
- VISKNDGJUCDNMS-UHFFFAOYSA-M potassium;chlorite Chemical compound [K+].[O-]Cl=O VISKNDGJUCDNMS-UHFFFAOYSA-M 0.000 claims description 4
- 229910001952 rubidium oxide Inorganic materials 0.000 claims description 4
- 239000010936 titanium Substances 0.000 claims description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 4
- 239000005909 Kieselgur Substances 0.000 claims description 3
- 229910021543 Nickel dioxide Inorganic materials 0.000 claims description 3
- QXIKMJLSPJFYOI-UHFFFAOYSA-L calcium;dichlorite Chemical compound [Ca+2].[O-]Cl=O.[O-]Cl=O QXIKMJLSPJFYOI-UHFFFAOYSA-L 0.000 claims description 3
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 claims description 3
- 229910052808 lithium carbonate Inorganic materials 0.000 claims description 3
- KAGBQTDQNWOCND-UHFFFAOYSA-M lithium;chlorite Chemical compound [Li+].[O-]Cl=O KAGBQTDQNWOCND-UHFFFAOYSA-M 0.000 claims description 3
- 229940073644 nickel Drugs 0.000 claims description 3
- 229910003445 palladium oxide Inorganic materials 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- WOHVONCNVLIHKY-UHFFFAOYSA-L [Ba+2].[O-]Cl=O.[O-]Cl=O Chemical compound [Ba+2].[O-]Cl=O.[O-]Cl=O WOHVONCNVLIHKY-UHFFFAOYSA-L 0.000 claims description 2
- 230000015271 coagulation Effects 0.000 claims 1
- 238000005345 coagulation Methods 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 230000001678 irradiating effect Effects 0.000 abstract description 21
- 239000013043 chemical agent Substances 0.000 abstract 7
- 238000012360 testing method Methods 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- 239000007789 gas Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 230000008859 change Effects 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000000463 material Substances 0.000 description 10
- 229920005989 resin Polymers 0.000 description 9
- 238000010586 diagram Methods 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 230000007423 decrease Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000004745 nonwoven fabric Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- -1 alkali metal chlorite Chemical class 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 229910001902 chlorine oxide Inorganic materials 0.000 description 4
- MAYPHUUCLRDEAZ-UHFFFAOYSA-N chlorine peroxide Chemical compound ClOOCl MAYPHUUCLRDEAZ-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000004378 air conditioning Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229940126589 solid medicine Drugs 0.000 description 3
- NHYCGSASNAIGLD-UHFFFAOYSA-N Chlorine monoxide Chemical compound Cl[O] NHYCGSASNAIGLD-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052625 palygorskite Inorganic materials 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000005245 sintering Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- SHFGJEQAOUMGJM-UHFFFAOYSA-N dialuminum dipotassium disodium dioxosilane iron(3+) oxocalcium oxomagnesium oxygen(2-) Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Na+].[Na+].[Al+3].[Al+3].[K+].[K+].[Fe+3].[Fe+3].O=[Mg].O=[Ca].O=[Si]=O SHFGJEQAOUMGJM-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NWAPVVCSZCCZCU-UHFFFAOYSA-L magnesium;dichlorite Chemical compound [Mg+2].[O-]Cl=O.[O-]Cl=O NWAPVVCSZCCZCU-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical group [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 108091008695 photoreceptors Proteins 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- CWBWCLMMHLCMAM-UHFFFAOYSA-M rubidium(1+);hydroxide Chemical compound [OH-].[Rb+].[Rb+] CWBWCLMMHLCMAM-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000029305 taxis Effects 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B11/00—Oxides or oxyacids of halogens; Salts thereof
- C01B11/02—Oxides of chlorine
- C01B11/022—Chlorine dioxide (ClO2)
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B11/00—Oxides or oxyacids of halogens; Salts thereof
- C01B11/02—Oxides of chlorine
- C01B11/022—Chlorine dioxide (ClO2)
- C01B11/023—Preparation from chlorites or chlorates
- C01B11/024—Preparation from chlorites or chlorates from chlorites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/44—Palladium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/30—Catalysts, in general, characterised by their form or physical properties characterised by their physical properties
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B11/00—Oxides or oxyacids of halogens; Salts thereof
- C01B11/02—Oxides of chlorine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Geology (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
- Catalysts (AREA)
Abstract
Description
本發明係關於二氧化氯產生用單元及二氧化氯產生裝置。詳細而言，係關於應用了將可見區域波長的光照射在包含固形的亞氯酸鹽之藥劑而產生二氧化氯之機制之小型二氧化氯產生用單元及具備該二氧化氯產生用單元之二氧化氯產生裝置。本發明，尤其適合裝載於車輛(例如自用車、公車、計程車等)或其他乘載工具(例如飛機、電車、船等)。此外，由於本發明之二氧化氯產生用單元為小型，故亦可組裝於例如暖氣機、冷氣機、空氣清淨機、加濕器等空調設備。 The present invention relates to a chlorine dioxide generating unit and a chlorine dioxide generating device. In detail, it relates to a small-sized chlorine dioxide generating unit using a mechanism for generating chlorine dioxide by irradiating light with a wavelength in the visible region to a chemical containing solid chlorite, and a unit equipped with the chlorine dioxide generating unit Chlorine dioxide generator. The present invention is particularly suitable for loading on vehicles (such as private cars, buses, taxis, etc.) or other riding tools (such as airplanes, trams, boats, etc.). In addition, since the chlorine dioxide generating unit of the present invention is small, it can also be incorporated in air conditioners such as heaters, air conditioners, air cleaners, and humidifiers.
以往，將紫外線照射在包含亞氯酸鹽之水溶液或包含亞氯酸鹽之凝膠劑等以產生二氧化氯之裝置已為人所知(例如專利文獻1)。然而，以往的二氧化氯製造裝置，並非考量攜行性而開發者，大多為大型化者。此外，以往的二氧化氯產生裝置，係以含有亞氯酸鹽之液體、或是包含此之凝膠狀物作為主成分(二氧化氯產生源)，欲直接攜行此等時，會有該主成分或廢液漏出之問題。再者， 就算是單純使它小型化而能夠攜行，亦會產生小型導致之新問題，亦即(亞氯酸鹽的絕對量不足)產生缺乏二氧化氯的產生持續性之新問題，因而難以持續使用。 Conventionally, devices that irradiate ultraviolet rays on an aqueous solution containing chlorite, a gel agent containing chlorite, or the like to generate chlorine dioxide have been known (for example, Patent Document 1). However, in the past, chlorine dioxide manufacturing equipment was not developed with consideration for portability, and most of them were large-scale ones. In addition, the conventional chlorine dioxide generating device uses a liquid containing chlorite or a gel containing the same as the main component (a source of chlorine dioxide generation). The leakage of the main component or waste liquid. Furthermore, Even if it is simply miniaturized and can be carried, it will cause new problems caused by small size, that is, (the absolute amount of chlorite is insufficient) produces new problems that lack the sustainability of chlorine dioxide production, so it is difficult to continue to use .
作為可同時解決二氧化氯產生裝置的「小型化」與「持續使用」之課題的裝置，為人所知者有一種將包含固形的亞氯酸鹽之藥劑包含於具備既定構造之匣，並照射紫外線而產生二氧化氯之裝置(專利文獻2)。 As a device that can simultaneously solve the problems of "miniaturization" and "sustained use" of a chlorine dioxide generating device, it is known that there is a medicine containing a solid chlorite in a box with a predetermined structure, and A device that generates chlorine dioxide by irradiating ultraviolet rays (Patent Document 2).
[專利文獻1]日本特開2005-224386號公報 [Patent Document 1] Japanese Unexamined Patent Publication No. 2005-224386
[專利文獻2]WO2011/118447 [Patent Literature 2] WO2011/118447
上述專利文獻2所述之裝置，與以往的二氧化氯產生裝置相比，從小型且可持續使用之觀點來看較優異。然而，該裝置，從使用固形的亞氯酸鹽作為二氧化氯產生源之觀點來看，與將紫外線照射在包含亞氯酸鹽之水溶液或包含亞氯酸鹽之凝膠劑以產生二氧化氯之裝置相比，具有二氧化氯的產生量低之進一步的課題。
The device described in the
以往，將光照射在包含固形的亞氯酸鹽之藥劑以產生二氧化氯時，為了更有效率地產生二氧化氯，已考量到在各種波長的光當中，必須使用能量較高之紫外 區域的光。 In the past, when irradiating light on a chemical containing solid chlorite to produce chlorine dioxide, in order to produce chlorine dioxide more efficiently, it has been considered that among various wavelengths of light, it is necessary to use ultraviolet light with higher energy Area light.
本案發明者們，對於增加使用包含固形的亞氯酸鹽之藥劑作為二氧化氯產生源之裝置的二氧化氯產生量進行精心探討。結果意外發現將紫外線照射在包含固形的亞氯酸鹽之藥劑時，不僅二氧化氯，甚至會產生臭氧，由於此臭氧與二氧化氯形成干涉，而使全體所產生之二氧化氯的量較臭氧的量減少(可參考本說明書的實施例1及第3圖)。 The inventors of the present application have carefully considered increasing the amount of chlorine dioxide produced by a device that uses a solid chlorite-containing agent as a source of chlorine dioxide production. As a result, it was unexpectedly found that when ultraviolet rays were irradiated on the agent containing solid chlorite, not only chlorine dioxide, but even ozone was generated. Because this ozone interfered with chlorine dioxide, the amount of chlorine dioxide generated by the whole was relatively high. The amount of ozone decreases (refer to Example 1 and Figure 3 of this specification).
本案發明者們根據上述發現，對於在使用包含固形的亞氯酸鹽之藥劑作為二氧化氯產生源之裝置中，一邊抑制臭氧的產生並增加全體所產生之二氧化氯的量進行更進一步的探討。結果發現，不使用以往從固形的亞氯酸鹽產生二氧化氯時被認為必要之紫外線，而是藉由使用可見區域的光，已可成功減少臭氧的產生量，並可增加裝置全體所產生之二氧化氯的量。 Based on the above findings, the inventors of the present invention further proceeded to further increase the amount of chlorine dioxide generated in the whole device while suppressing the generation of ozone in a device using a solid chlorite-containing agent as a source of chlorine dioxide generation. Explore. As a result, it was found that instead of using the ultraviolet rays that were considered necessary when producing chlorine dioxide from solid chlorite, it was possible to successfully reduce the amount of ozone produced by using light in the visible region and increase the amount produced by the entire device. The amount of chlorine dioxide.
再者，本案發明者們為了彌補因採用能量較紫外線低之可見區域的光所造成之反應性降低，再探討裝置的改良，結果驚訝發現，從複數個光源部將光照射在包含固形的亞氯酸鹽之藥劑時，可“相乘”地提升二氧化氯地產生效率。 In addition, the inventors of the present application explored the improvement of the device in order to compensate for the decrease in the reactivity caused by the use of light in the visible region with a lower energy than ultraviolet rays. As a result, they were surprised to find that light from a plurality of light source parts was irradiated on When the chlorate agent is used, it can "multiply" the production efficiency of chlorine dioxide.
再者，本案發明者們發現，本發明之二氧化氯產生用單元中的藥劑容納部係以通氣性薄片覆蓋，而可防止藥劑容納部中含有固形的亞氯酸鹽的藥劑翻出，同時藉由通氣防止藥劑過度的乾燥或是過度的濕潤，可使裝 置更安定地放出二氧化氯。 Furthermore, the inventors of the present invention have discovered that the drug storage portion in the chlorine dioxide generating unit of the present invention is covered with a breathable sheet, which can prevent the drug containing solid chlorite in the drug storage portion from turning out, and at the same time By ventilating to prevent excessive drying or excessive wetting The chlorine dioxide is released more stably.
藉由此等創意作法，本案發明者們已完成一種小型且可涵蓋極長時間釋出實用上為充分量之二氧化氯之本發明之二氧化氯產生用單元，以及具備該單元之二氧化氯產生裝置。 Through these creative methods, the inventors of the present invention have completed a small-sized unit for producing chlorine dioxide of the present invention that can release a practically sufficient amount of chlorine dioxide for a very long time, and a dioxide equipped with the unit Chlorine generating device.
亦即，本發明，於其一實施形態中，係關於一種二氧化氯產生用單元，其特徵為：前述單元具備藥劑容納部及至少2個光源部，前述光源部用以產生實質上由可見區域的波長所構成之光，於前述藥劑容納部容納有包含固形的亞氯酸鹽之藥劑，於前述藥劑容納部，以使空氣可在前述藥劑容納部的內部與外部移動之方式具備1個或複數個開口部，前述藥劑容納部之前述1個或複數個開口部係由通氣性薄片所覆蓋，在此，存在於前述藥劑容納部的內部之前述藥劑，係以由前述光源部所產生之前述光照射而產生二氧化氯氣體。 That is, the present invention, in one embodiment thereof, relates to a unit for generating chlorine dioxide, characterized in that the unit is provided with a drug storage portion and at least two light source portions, and the light source portion is used to generate a substantially visible The light constituted by the wavelength of the region contains a drug containing solid chlorite in the drug storage part, and the drug storage part is provided with one so that air can move inside and outside the drug storage part Or a plurality of openings, the one or a plurality of openings of the medicine containing part are covered by a breathable sheet, and here, the medicine existing inside the medicine containing part is generated by the light source part The aforementioned light irradiation generates chlorine dioxide gas.
此外，本發明之二氧化氯產生用單元，於一實施形態中，其特徵為：前述藥劑容納部與前述至少2個光源部係一體配置，前述至少2個光源部，對於容納於前述藥劑容納部之前述藥劑，從至少2個方向照射光線。 In addition, in one embodiment, the chlorine dioxide generating unit of the present invention is characterized in that the drug storage portion and the at least two light source portions are integrally arranged, and the at least two light source portions are provided for the drug storage The aforementioned medicament of the department irradiates light from at least two directions.
此外，本發明之二氧化氯產生用單元，於一實施形態中，其特徵為：前述照射之光的波長為360nm至450nm。 Furthermore, in one embodiment, the chlorine dioxide generating unit of the present invention is characterized in that the wavelength of the irradiated light is 360 nm to 450 nm.
此外，本發明之二氧化氯產生用單元，於一實施形態中，其特徵為：前述光源部係具備燈或是晶片。 In addition, in one embodiment, the unit for generating chlorine dioxide of the present invention is characterized in that the light source unit includes a lamp or a chip.
此外，本發明之二氧化氯產生用單元，於一實施形態中，其特徵為：前述晶片為LED晶片。 In addition, in one embodiment, the unit for generating chlorine dioxide of the present invention is characterized in that the wafer is an LED wafer.
此外，本發明之二氧化氯產生用單元，於一實施形態中、其特徵為：前述光源部為可間歇性地照射光線之光源部。 In addition, in one embodiment, the unit for generating chlorine dioxide of the present invention is characterized in that the light source unit is a light source unit that can irradiate light intermittently.
此外，本發明之二氧化氯產生用單元，於一實施形態中，其特徵為：前述包含固形的亞氯酸鹽之藥劑，為包含(A)載持亞氯酸鹽之多孔質物質、及(B)金屬觸媒或金屬氧化物觸媒之藥劑。 Furthermore, in one embodiment, the unit for generating chlorine dioxide of the present invention is characterized in that the aforementioned agent containing solid chlorite is (A) a porous substance supporting chlorite, and (B) Metal catalyst or metal oxide catalyst agent.
此外，本發明之二氧化氯產生用單元，於一實施形態中，其特徵為：前述「載持亞氯酸鹽之多孔質物質」，係將亞氯酸鹽水溶液含浸於多孔質物質並乾燥而得。 In addition, the chlorine dioxide generating unit of the present invention, in one embodiment, is characterized in that the aforementioned "porous substance carrying chlorite" impregnates the porous substance with an aqueous solution of chlorite and dries it. Got.
此外，本發明之二氧化氯產生用單元，於一實施形態中，其特徵為：前述金屬觸媒或金屬氧化物觸媒，係選自由鈀、銣、鎳、鈦、及二氧化鈦所組成之群組。 In addition, in one embodiment, the unit for generating chlorine dioxide of the present invention is characterized in that the aforementioned metal catalyst or metal oxide catalyst is selected from the group consisting of palladium, rubidium, nickel, titanium, and titanium dioxide group.
此外，本發明之二氧化氯產生用單元，於一實施形態中，其特徵為：前述多孔質物質，係選自由海泡石(Sepiolite)、山軟木石(Palygorskite)、蒙特石(Montmorillonite)、二氧化矽凝膠、矽藻土、沸石(Zeolite)、及珍珠岩(Perlite)所組成之群組； 前述亞氯酸鹽，係選自由亞氯酸鈉、亞氯酸鉀、亞氯酸鋰、亞氯酸鈣、及亞氯酸鋇所組成之群組。 In addition, in one embodiment, the unit for generating chlorine dioxide of the present invention is characterized in that the porous material is selected from the group consisting of sepiolite, palygorskite, montmorillonite, The group consisting of silica gel, diatomaceous earth, zeolite (Zeolite), and perlite (Perlite); The aforementioned chlorite is selected from the group consisting of sodium chlorite, potassium chlorite, lithium chlorite, calcium chlorite, and barium chlorite.
此外，本發明之二氧化氯產生用單元，於 一實施形態中，其特徵為：於前述藥劑容納部中的前述藥劑中，前述亞氯酸鹽與前述金屬觸媒或金屬氧化物觸媒之質量比，為1：0.04至0.8。 In addition, the unit for producing chlorine dioxide of the present invention is In one embodiment, the mass ratio of the chlorite to the metal catalyst or metal oxide catalyst in the drug in the drug storage portion is 1:0.04 to 0.8.
此外，本發明之二氧化氯產生用單元，於一實施形態中，其特徵為：前述多孔質物質更載持鹼劑。 Furthermore, in one embodiment, the unit for generating chlorine dioxide of the present invention is characterized in that the porous substance further supports an alkaline agent.
此外，本發明之二氧化氯產生用單元，於一實施形態中，其特徵為：前述鹼劑係選自由氫氧化鈉、氫氧化鉀、氫氧化鋰、碳酸鈉、碳酸鉀、及碳酸鋰所組成之群組。 In addition, in one embodiment, the unit for generating chlorine dioxide of the present invention is characterized in that the alkali agent is selected from the group consisting of sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, and lithium carbonate. Formed into groups.
此外，本發明之二氧化氯產生用單元，於一實施形態中，其特徵為：前述藥劑中之前述亞氯酸鹽與前述鹼劑之莫耳比，為1：0.1至2.0。 In addition, in one embodiment, the unit for generating chlorine dioxide of the present invention is characterized in that the molar ratio of the chlorite to the alkaline agent in the chemical is 1:0.1 to 2.0.
此外，本發明之二氧化氯產生用單元，於一實施形態中，其特徵為：前述「載持亞氯酸鹽及鹼劑之多孔質物質」，係同時或依序將亞氯酸鹽及鹼劑含浸於多孔質物質並乾燥而得。 In addition, in one embodiment, the unit for generating chlorine dioxide of the present invention is characterized in that the aforementioned “porous substance supporting chlorite and alkali agent” is a method for simultaneously or sequentially Alkali agent is impregnated with porous material and dried.
本發明的其他實施形態，係關於一種二氧化氯產生裝置，其係具備上述任一項所述之二氧化氯產生用單元者。 Another embodiment of the present invention relates to a chlorine dioxide generating device provided with the chlorine dioxide generating unit according to any one of the above.
此外，本發明之二氧化氯產生裝置，於一實施形態中，其特徵為更具備：將空氣傳送至前述二氧化氯產生用單元中之容納於前述藥劑容納部之藥劑之送風部。 In addition, in one embodiment, the chlorine dioxide generating device of the present invention is characterized by further comprising: an air blower that sends air to the chemical storage unit contained in the chemical storage unit in the chlorine dioxide generating unit.
此外，本發明之二氧化氯產生裝置，於一 實施形態中，其特徵為：前述送風部，為從前述二氧化氯產生裝置的外部將空氣引入於內部之風扇，或是從前述二氧化氯產生裝置的內部將空氣釋出至外部之風扇。 In addition, the chlorine dioxide generating device of the present invention In an embodiment, the air supply part is a fan that introduces air into the inside from the outside of the chlorine dioxide generating device, or a fan that releases air from the inside of the chlorine dioxide generating device to the outside.
此外，本發明之二氧化氯產生裝置，於一實施形態中，其特徵為：前述藥劑容納部的開口部中之至少1個，存在於前述藥劑容納部的側面，從前述送風部送來之空氣，至少一部分經由存在於前述藥劑容納部的側面之開口部傳送至藥劑。 In addition, in one embodiment, the chlorine dioxide generating device of the present invention is characterized in that at least one of the openings of the drug storage portion exists on the side of the drug storage portion and is sent from the air blowing portion At least a part of the air is transported to the medicine through the opening portion existing on the side of the medicine storage portion.
此外，本發明之二氧化氯產生裝置，於一實施形態中，其特徵為：前述藥劑容納部中的相對濕度，係藉由從前述送風部送來之空氣保持在30至80%RH。 In addition, in one embodiment, the chlorine dioxide generating device of the present invention is characterized in that the relative humidity in the medicine storage section is maintained at 30 to 80% RH by the air sent from the blowing section.
以從該業者的觀點來看技術上不矛盾之方式任意地組合上述本發明的一項或複數項特徵而成者，當然亦包含於本發明之範圍。 Those who arbitrarily combine one or more of the features of the present invention described above in a technically non-contradictory manner from the perspective of the industry are of course included in the scope of the present invention.
本發明之二氧化氯產生用單元及具備該單元之二氧化氯產生裝置，藉由採用上述構成，因可達成小型化，且可涵蓋極長時間釋出實用上為充分量之二氧化氯，所以可適合使用在例如乘載工具裝載用。此外，由於本發明之二氧化氯產生用單元為小型，故亦可組裝於例如暖氣機、冷氣機、空氣清淨機、加濕器等空調設備。 The chlorine dioxide generating unit and the chlorine dioxide generating device provided with the unit of the present invention, by adopting the above-mentioned configuration, can achieve miniaturization and can cover a long time to release a sufficient amount of chlorine dioxide in practical use, Therefore, it can be suitably used for, for example, loading a vehicle. In addition, since the chlorine dioxide generating unit of the present invention is small, it can also be incorporated in air conditioners such as heaters, air conditioners, air cleaners, and humidifiers.
10、21、30‧‧‧二氧化氯產生用單元 10, 21, 30‧‧‧ Unit for generating chlorine dioxide
11、32、42‧‧‧藥劑容納部 11, 32, 42
12、34‧‧‧LED晶片 12, 34‧‧‧LED chip
13‧‧‧操作基板 13‧‧‧Operation board
14‧‧‧藥劑 14‧‧‧Pharmacy
15‧‧‧管 15‧‧‧ tube
16‧‧‧開口部 16‧‧‧Opening
20、40‧‧‧二氧化氯產生用裝置 20, 40‧‧‧ Chlorine dioxide generating device
22‧‧‧裝置本體 22‧‧‧device body
23‧‧‧空氣供給口 23‧‧‧Air supply port
24‧‧‧風扇 24‧‧‧Fan
25‧‧‧空氣排出口 25‧‧‧Air outlet
31‧‧‧氣體產生口 31‧‧‧ gas generation port
33‧‧‧電子基板 33‧‧‧Electronic substrate
35‧‧‧外裝部 35‧‧‧External Department
36‧‧‧氣體導入口 36‧‧‧Gas inlet
41‧‧‧LED晶片裝著基板 41‧‧‧LED chip mounted substrate
43‧‧‧框體部 43‧‧‧frame
44‧‧‧送風風扇 44‧‧‧Supply fan
51‧‧‧透明樹脂板 51‧‧‧Transparent resin board
52‧‧‧藥劑容納部 52‧‧‧Pharmacy storage
53‧‧‧通氣性薄片 53‧‧‧Ventilation sheet
54‧‧‧LED晶片裝著基板 54‧‧‧LED chip mounted substrate
55‧‧‧藥劑容納部 55‧‧‧Pharmaceutical Department
56‧‧‧送風風扇 56‧‧‧Supply fan
第1圖係顯示裝入有包含固形的亞氯酸鹽之藥劑之二 氧化氯產生用單元之縱向剖面圖。 Figure 1 shows the second of the agents containing solid chlorite A longitudinal cross-sectional view of a unit for generating chlorine oxide.
第2圖係顯示組裝有第1圖的二氧化氯產生用單元之二氧化氯產生裝置之縱向剖面圖。 Fig. 2 is a longitudinal cross-sectional view of a chlorine dioxide generating device incorporating the chlorine dioxide generating unit of Fig. 1;
第3圖係顯示將光照射在包含固形的亞氯酸鹽之藥劑時，改變所照射之光的波長時空氣中的二氧化氯濃度及臭氧濃度實測值的變化之圖表。 Figure 3 is a graph showing changes in the measured values of chlorine dioxide concentration and ozone concentration in the air when light is irradiated to a drug containing solid chlorite, and the wavelength of the irradiated light is changed.
第4圖係顯示於第3圖中之二氧化氯濃度及臭氧濃度的實測值中，紫外區域中之測定值的平均值與可見區域中之測定值的平均值之圖表。 Fig. 4 is a graph showing the average value of the measured value in the ultraviolet region and the average value of the measured value in the visible region among the measured values of the chlorine dioxide concentration and the ozone concentration in Fig. 3.
第5圖係顯示將光照射在包含固形的亞氯酸鹽之藥劑時，由混合於藥劑之金屬觸媒或金屬氧化物觸媒的形狀所造成之二氧化氯產生量的變化之圖表。 Figure 5 is a graph showing the change in the amount of chlorine dioxide produced by the shape of the metal catalyst or metal oxide catalyst mixed with the drug when light is irradiated to the drug containing solid chlorite.
第6圖係顯示於包含固形的亞氯酸鹽及金屬觸媒或金屬氧化物觸媒(二氧化鈦)之藥劑中，改變亞氯酸鹽與二氧化鈦的比率時之二氧化氯產生量的變化。 Figure 6 shows the change in the amount of chlorine dioxide produced when the ratio of chlorite to titanium dioxide is changed in a drug containing solid chlorite and a metal catalyst or metal oxide catalyst (titanium dioxide).
第7圖係顯示於包含固形的亞氯酸鹽及金屬觸媒或金屬氧化物觸媒(二氧化鈦)之藥劑中，二氧化鈦的含量與因照射可見光所產生之二氧化氯濃度的最大值之關係。 Figure 7 shows the relationship between the content of titanium dioxide and the maximum concentration of chlorine dioxide produced by visible light irradiation in a chemical containing solid chlorite and a metal catalyst or metal oxide catalyst (titanium dioxide).
第8圖係顯示將可見光長時間持續照射在包含固形的亞氯酸鹽及金屬觸媒或金屬氧化物觸媒(二氧化鈦)之藥劑時之二氧化氯產生量的變化。 Fig. 8 shows the change in the amount of chlorine dioxide generated when the visible light is continuously irradiated to the agent containing the solid chlorite and the metal catalyst or metal oxide catalyst (titanium dioxide).
第9圖係顯示本發明的一實施形態之二氧化氯產生用單元之立體圖、上視圖及側視圖。 Fig. 9 is a perspective view, a top view and a side view of a chlorine dioxide generating unit according to an embodiment of the present invention.
第10圖係顯示組裝有本發明的一實施形態之二氧化 氯產生用單元之二氧化氯產生裝置之概略圖。 Figure 10 is a diagram showing an embodiment of the present invention is assembled with dioxide Schematic diagram of the chlorine dioxide generating unit of the chlorine generating unit.
第11圖係顯示於本發明的一實施形態之二氧化氯產生用單元中，對藥劑容納部中的藥劑，僅從1個光源部(單面)照射光線時與從2個光源部(雙面)照射光線時之二氧化氯產生量的比較。 FIG. 11 shows that in the unit for generating chlorine dioxide according to an embodiment of the present invention, when the medicine in the medicine storage section is irradiated with light from only one light source section (single side) and from two light source sections (double (Surface) Comparison of the amount of chlorine dioxide produced when exposed to light.
第12圖係顯示於本發明的一實施形態之二氧化氯產生用單元中，對藥劑容納部中的藥劑，僅從1個光源部(單面)照射光線時與從2個光源部(雙面)照射光線時，點繪出二氧化氯產生量的比之圖。從2個光源部(雙面)照射光線時，與僅從1個光源部(單面)照射光線時相比，為了顯示二氧化氯的產生量成為2倍以上，取得二氧化氯產生量的比時係採用單面照射時二氧化氯產生量之2倍值。 FIG. 12 is a diagram showing a unit for generating chlorine dioxide in an embodiment of the present invention, when the medicine in the medicine storage part is irradiated with light from only one light source part (single side) and from two light source parts (double (Surface) When irradiating light, plot the ratio of the amount of chlorine dioxide produced. When light is irradiated from two light source parts (double-sided), compared with when only one light source part (single side) is irradiated, in order to show that the amount of generated chlorine dioxide is more than doubled, the amount of generated chlorine dioxide is obtained. The specific time is the double value of the amount of chlorine dioxide produced by single-sided irradiation.
第13圖係說明於本發明的一實施形態之二氧化氯產生用單元中，從2個光源部(雙面)照射光線時與僅從1個光源部(單面)照射光線時相比，可有效率地使光到達藥劑容納部中的藥劑之圖。 FIG. 13 illustrates that in the unit for generating chlorine dioxide according to an embodiment of the present invention, when light is irradiated from two light source parts (both sides) compared to when only one light source part (single side) is irradiated, The light can efficiently reach the map of the medicine in the medicine storage portion.
第14圖係顯示於本發明的一實施形態之二氧化氯產生用單元中，改變藥劑容納部中的相對濕度時之二氧化氯產生量的變化。第14圖中，係顯示僅從1個光源部(單面)照射光線時之資料。 FIG. 14 is a graph showing the change in the amount of chlorine dioxide generated when the relative humidity in the drug storage section is changed in the unit for generating chlorine dioxide according to an embodiment of the present invention. Figure 14 shows data when only one light source (single side) is irradiated with light.
第15圖係顯示於本發明的一實施形態之二氧化氯產生用單元中，改變藥劑容納部中的相對濕度時之二氧化氯產生量的經時變化。第15圖中，係顯示從2個光源部(雙面)照射光線時之資料。 Fig. 15 is a graph showing changes over time in the amount of chlorine dioxide generated when the relative humidity in the drug storage unit is changed in the chlorine dioxide generating unit according to an embodiment of the present invention. Figure 15 shows the data when light is irradiated from two light source parts (both sides).
第16圖係顯示於本發明的一實施形態之二氧化氯產生用單元中，對藥劑容納部中的藥劑，從2個光源部(雙面)間歇性地照射光線時之二氧化氯產生量的經時變化。圖中所謂「10s/80s」，係表示：照射開始的2分鐘內持續照射光線，照射開始的2分鐘後重複進行照射光線10秒(開啟LED)、停止照射光線80秒(關閉LED)之循環。同樣的，圖中的「20s/80s」，係表示：照射開始的2分鐘內持續照射光線，照射開始的2分鐘後重複進行照射光線20秒(開啟LED)、停止照射光線80秒(關閉LED)之循環。「30s/80s」，係表示：照射開始的2分鐘內持續照射光線，照射開始的2分鐘後重複進行照射光線30秒(開啟LED)、停止照射光線80秒(關閉LED)之循環。 Fig. 16 is a graph showing the amount of chlorine dioxide generated when intermittently irradiating light from two light source sections (both sides) of a drug in a drug storage unit in a chlorine dioxide generating unit according to an embodiment of the present invention Changes over time. The so-called "10s/80s" in the figure means that the light is continuously irradiated for 2 minutes after the start of irradiation, and the cycle of irradiating the light for 10 seconds (turning on the LED) and stopping the light for 80 seconds (turning off the LED) is repeated 2 minutes after the start of irradiation . Similarly, "20s/80s" in the figure means that the light is continuously irradiated for 2 minutes after the start of the irradiation, and the light is repeated for 20 seconds (turn on the LED) and stop the light for 80 seconds (turn off the LED) ) Cycle. "30s/80s" means that the light is continuously irradiated for 2 minutes after the start of irradiation, and the cycle of irradiating the light for 30 seconds (turning on the LED) and stopping the light for 80 seconds (turning off the LED) is repeated 2 minutes after the start of irradiation.
第17圖係顯示為將本發明之二氧化氯產生單元之藥劑容納部以通氣性薄片覆蓋之構造時之實施形態。 Fig. 17 shows an embodiment in a structure in which the medicine storage portion of the chlorine dioxide generating unit of the present invention is covered with a breathable sheet.
第18圖係顯示於組裝有第17圖中記載的藥劑容納部之二氧化氯產生裝置中，藉由大部分流經裝置中的空氣以拂掃藥劑容納部的表面的方式流動，僅有一部分的空氣於藥劑容納部的內外來回移動，而能夠安定放出二氧化氯。 Figure 18 shows that in the chlorine dioxide generating device equipped with the drug storage part shown in Figure 17, most of the air flowing through the device flows to sweep the surface of the drug storage part, only a part The air moves back and forth inside and outside the medicine storage part, and can release chlorine dioxide stably.
本發明，於一實施形態中，係關於一種二氧化氯產生用單元，其特徵為：前述單元具備藥劑容納部及至少2個光源部，前述光源部用以產生實質上由可見區域的波長所構成之光，於前述藥劑容納部容納有包含固形的亞氯酸鹽之藥劑，於前述藥劑容納部，以使空氣可在前 述藥劑容納部的內部與外部移動之方式具備1個或複數個開口部，前述藥劑容納部之前述1個或複數個開口部係由通氣性薄片所覆蓋，在此，存在於前述藥劑容納部的內部之前述藥劑，係以由前述光源部所產生之前述光照射而產生二氧化氯氣體。 The present invention, in one embodiment, relates to a unit for generating chlorine dioxide, characterized in that the unit is provided with a drug storage portion and at least two light source portions, and the light source portion is used to generate the light wavelength substantially in the visible region The structured light contains a medicine containing solid chlorite in the medicine containing portion, so that air can be in front of the medicine containing portion One or a plurality of openings are provided in such a way that the inside and the outside of the medicine containing part move, and the one or a plurality of openings of the medicine containing part are covered by a breathable sheet, and here, exist in the medicine containing part The inside of the medicine is irradiated with the light generated by the light source to generate chlorine dioxide gas.
本發明之二氧化氯產生用單元中，具備至少2個光源部(例如2、3、4、5、6或以上個數的光源部)，該至少2個光源部的位置關係，只要是對於二氧化氯的產生源之藥劑，從至少2個方向(例如2、3、4、5、6或以上之方向)照射光線即可，並無特別限定。較佳者，至少2個光源部係配置在以二氧化氯的產生源之藥劑為中心呈對稱之位置。 The unit for generating chlorine dioxide of the present invention includes at least two light source sections (for example, 2, 3, 4, 5, 6 or more light source sections), and the positional relationship of the at least two light source sections is as long as The agent for generating chlorine dioxide may be irradiated with light from at least two directions (for example, directions of 2, 3, 4, 5, 6 or more), and is not particularly limited. Preferably, at least two light source sections are arranged at positions symmetrical about the agent that generates chlorine dioxide.
本發明所使用之光源，只要是可釋出單獨可見區域的光或是包含可見區域的光者即可，可使用以往所知的光源。因此，由本發明所使用之光源所產生之光的波長，並不僅限定於可見區域的光之波長(360nm至830nm)，亦可為包含紫外區域的光之波長(360nm以下)以及紅外區域的光之波長(830nm以上)之光。然而，將紫外區域之波長的光照射在包含固形的亞氯酸鹽之藥劑時，容易產生作為副產物的臭氧，此外，由於紅外區域之波長的光能量弱，故即使照射在包含固形的亞氯酸鹽之藥劑，所產生之二氧化氯的量亦少。因此，由本發明所使用之光源所產生之光，較佳係實質上由可見區域之波長的光所構成。由本發明所使用之光源所產生之光，較佳為360nm至 450nm之波長的光，更佳為380nm至450nm或360nm至430nm之波長的光，最佳為380nm至430nm之波長的光。 The light source used in the present invention may be any one that can emit light in a separate visible region or includes light in the visible region, and a conventionally known light source can be used. Therefore, the wavelength of light generated by the light source used in the present invention is not limited to the wavelength of light in the visible region (360nm to 830nm), but also includes the wavelength of light in the ultraviolet region (below 360nm) and light in the infrared region Wavelength (above 830nm). However, when light with a wavelength in the ultraviolet region is irradiated to a medicine containing solid chlorite, ozone is easily generated as a by-product. In addition, since the light energy with a wavelength in the infrared region is weak, even if it is irradiated with a solid The amount of chlorine dioxide produced by the chlorate reagent is also small. Therefore, the light generated by the light source used in the present invention is preferably substantially composed of light with a wavelength in the visible region. The light generated by the light source used in the present invention is preferably 360 nm to Light with a wavelength of 450 nm is more preferably light with a wavelength of 380 nm to 450 nm or 360 nm to 430 nm, and most preferably light with a wavelength of 380 nm to 430 nm.
由光源所產生之光的波長實質上包含於特定波長區域的範圍，可藉由一般所知的測定機器測定由光源所產生之光的波長或能量而確認。 The wavelength of the light generated by the light source is substantially included in a specific wavelength range, and can be confirmed by measuring the wavelength or energy of the light generated by the light source by a generally known measuring device.
本發明所使用之光源，只要是可產生可見區域之波長的光者即可，並無特別限定，例如可使用產生可見區域的光之燈(白熾燈、LED燈)、晶片、雷射裝置等各種。從由光源所產生之光的指向性之觀點來看，此外，從裝置的小型化之觀點來看，光源較佳係使用晶片形態者。晶片形態的光源，由於指向性狹窄，所以光不會擴散，可有效率地將光照射在照射的對象物，而提升裝置的二氧化氯產生效率。此外，從限定由光源所產生之光的波長使其不含紫外區域或紅外區域的光之觀點來看，光源較佳係使用產生可見區域的光之LED。尤其從裝置的小型化之觀點以及二氧化氯產生效率之觀點來看，本發明所使用之光源，最佳為產生可見區域的光之LED晶片。 The light source used in the present invention is not particularly limited as long as it can produce light of a wavelength in the visible region, for example, a lamp (incandescent lamp, LED lamp), chip, laser device, etc. that can produce light in the visible region can be used. Various. From the viewpoint of the directivity of the light generated by the light source, and from the viewpoint of miniaturization of the device, the light source is preferably in the form of a wafer. Since the light source in the form of a wafer has a narrow directivity, light does not diffuse, and the light can be efficiently irradiated to the object to be irradiated, thereby improving the chlorine dioxide generation efficiency of the device. In addition, from the viewpoint of limiting the wavelength of light generated by the light source so that it does not contain light in the ultraviolet region or the infrared region, the light source is preferably an LED that generates light in the visible region. Especially from the viewpoint of miniaturization of the device and the viewpoint of chlorine dioxide generation efficiency, the light source used in the present invention is preferably an LED chip that generates light in a visible region.
此外，本發明所使用之光源，亦可為可間歇性地照射光線之光源。例如本發明所使用之光源，可為重複進行在照射一定時間的光線後停止一定時間之光線照射之循環之光源。用以間歇性地照射光線之光源的控制方法並無特別限定，可使用該業者一般所知的方法來實施。 In addition, the light source used in the present invention may also be a light source that can radiate light intermittently. For example, the light source used in the present invention may be a light source that repeats the cycle of stopping the light irradiation for a certain period of time after irradiating the light for a certain period of time. The control method of the light source used to irradiate light intermittently is not particularly limited, and can be implemented by a method generally known by the industry.
本發明之二氧化氯產生裝置中的光源部與藥劑容納部，可一體配置或分離配置，但為了將由光源部 所產生之光有效率地照射在容納於藥劑容納部之藥劑，較佳係一體配置。在此，光源部與藥劑容納部，可為以不可分離的型態一體配置或連接，或是以可分離的型態一體配置或連接。當光源部與藥劑容納部以可分離的型態一體配置或連接時，藥劑容納部可為可更換之匣。 In the chlorine dioxide generating device of the present invention, the light source unit and the drug storage unit may be arranged integrally or separately, but in order to The generated light efficiently irradiates the medicament contained in the medicament accommodating portion, and is preferably integrally arranged. Here, the light source part and the medicine containing part may be integrally arranged or connected in an inseparable form, or integrally arranged or connected in a separable form. When the light source part and the medicine accommodating part are integrally arranged or connected in a detachable form, the medicine accommodating part may be a replaceable cartridge.
本發明所使用之藥劑容納部，只要是以使空氣可在內部與外部移動之方式具備1個或複數個開口部即可，該原材料或構造並無限定。例如，可將藥劑容納部(尤其藥劑容納部中被來自光源部的光直接照射之面)的原材料構成為一般所知的光穿透性原材料，藉此可將由光源部所照射之光照射至藥劑容納部內部的藥劑。較佳係將實質上可讓可見區域的光穿透之樹脂製成藥劑容納部的原材料，藉此可使由光源部所產生之光不被樹脂吸收而照射至藥劑容納部內部的藥劑。本說明書中，實質上可讓可見區域之波長的光穿透之樹脂，例如為可讓所照射之可見區域之波長的光的80%以上穿透之樹脂，較佳為可讓所照射之可見區域之波長的光的90%以上穿透之樹脂，更佳為可讓所照射之可見區域之波長的光的95%以上穿透之樹脂。具體而言，藥劑容納部中之來自光源部的光所直接照射之面的原材料，可使用例如丙烯酸製、氯乙烯製、或PET製的材料，但並不特別限定於此等。 The drug storage portion used in the present invention may be provided with one or a plurality of openings so that air can move inside and outside, and the raw material or structure is not limited. For example, the raw material of the medicine storage section (especially the surface of the medicine storage section directly irradiated with light from the light source section) can be constituted as a generally known light-transmissive raw material, whereby the light irradiated by the light source section can be irradiated to The medicine inside the medicine storage part. It is preferable to use a resin that substantially allows light in the visible region to pass through to make the raw material of the medicine containing portion, whereby the light generated by the light source portion can be irradiated to the medicine inside the medicine containing portion without being absorbed by the resin. In this specification, a resin that can substantially transmit the light of the wavelength in the visible region, for example, a resin that can transmit more than 80% of the light of the wavelength of the visible region that is irradiated, preferably the one that can make the irradiated visible A resin that penetrates more than 90% of the light of the wavelength of the region, and more preferably a resin that can penetrate more than 95% of the light of the wavelength of the visible region irradiated. Specifically, as the raw material on the surface directly irradiated with the light from the light source part in the drug storage part, for example, a material made of acrylic, vinyl chloride, or PET can be used, but it is not particularly limited thereto.
此外，例如亦可藉由具有不會讓容納物掉落程度的網目之網狀板來構成藥劑容納部。根據此構成，藥劑容納部外部的空氣可於藥劑容納部的內部與外部移 動，由光源部所產生之光可通過網目照射至藥劑容納部內部的藥劑。 In addition, for example, the medicine storage portion may be constituted by a mesh plate having a mesh that does not allow the contents to fall. According to this configuration, the air outside the medicine accommodating part can move inside and outside the medicine accommodating part The light generated by the light source part can be irradiated to the drug inside the drug storage part through the mesh.
此外，本發明中藥劑容納部之1個或複數個開口部係由通氣性薄片所覆蓋。本說明書中，「通氣性薄片」係指使氣體(例如，空氣、氣體、濕氣等)通過，但使固形的物質(例如，粉狀的物體、粒狀的物體)實質上不通過的薄片狀構造。本發明中的「通氣性薄片」可進一步具有使液體(例如，水滴)實質上不通過的性質。本發明中通氣性薄片的素材雖無限定，但例如可例示為將纖維藉由熱/機械或是化學作用接著或是交纏而成為薄片狀的素材、微多孔質膜(有大量非常小的孔之素材之膜)單獨或是重疊貼合複數片的素材、或是雖然為無孔質但可讓氣體、空氣或濕氣(水蒸氣)移動的素材、對高密度織物施有強力的撥水處理的塗布型素材，或者是，將該等素材組合而形成的素材。更具體而言，作為本發明中的通氣性薄片，例如可使用不織布(ELEVES(註冊商標、由尼帝佳公司製)、AXTAR(註冊商標、TORAY公司製)等)、GORE-TEX(註冊商標)與EXEPOL(註冊商標、三菱樹脂公司製：組合微多孔質聚烯烴系膜與各種不織布之通氣性/透濕性/防水性優異的素材)、Entrant E(註冊商標、TORAY公司製)等。另外，本發明中，通氣性薄片為了易於裝設於藥劑容納部，係期望具備熱封性(熱溶著性)。 In addition, in the present invention, one or a plurality of openings of the drug storage portion are covered with a breathable sheet. In this specification, "air-permeable sheet" refers to a sheet that passes gas (for example, air, gas, moisture, etc.) but does not substantially pass solid substances (for example, powdery objects or granular objects). structure. The "breathable sheet" in the present invention may further have a property that does not substantially pass liquid (for example, water droplets). The material of the air-permeable sheet in the present invention is not limited, but it can be exemplified as a sheet-like material or microporous membrane (there are a large number of very small The film of the material of the hole) alone or overlapping a plurality of materials or materials that are non-porous but can move gas, air or moisture (water vapor), and apply a strong dial to high-density fabrics A coating material for water treatment, or a material formed by combining these materials. More specifically, as the air-permeable sheet in the present invention, for example, non-woven fabric (ELEVES (registered trademark, manufactured by Nidijia), AXTAR (registered trademark, manufactured by TORAY), etc.), GORE-TEX (registered trademark) can be used. ), EXEPOL (registered trademark, manufactured by Mitsubishi Resin Co., Ltd.: a combination of microporous polyolefin-based membrane and various non-woven materials with excellent air permeability/moisture permeability/water resistance), Entrant E (registered trademark, manufactured by TORAY), etc. In addition, in the present invention, the air-permeable sheet is desirably provided with heat-sealability (heat-solubility) in order to be easily installed in the drug storage portion.
本發明中所使用之通氣性薄片的形狀及厚度，只要該通氣性薄片可達到於藥劑容納部的內部與外部 之邊界「使氣體、空氣或濕氣通過，但有一定大小以上的物體不通過」的目的，所屬技術領域中具有通常知識者即可適當地選擇。例如，使用不織布作為通氣性薄片時，可使用網目為15至120g/m2(較佳為40至100g/m2、更佳為50至80g/m2)，厚度為0.1至1.0mm(較佳為0.2至0.5mm、更佳為0.2至0.4mm)者。 The shape and thickness of the air-permeable sheet used in the present invention, as long as the air-permeable sheet can reach the boundary between the inside and the outside of the medicine containing portion "passes gas, air, or moisture, but objects of a certain size or more do not pass For the purpose of ", those with ordinary knowledge in the technical field can appropriately choose. For example, when non-woven fabric is used as the air-permeable sheet, a mesh of 15 to 120 g/m 2 (preferably 40 to 100 g/m 2 , more preferably 50 to 80 g/m 2 ) and a thickness of 0.1 to 1.0 mm (compared to It is preferably 0.2 to 0.5 mm, more preferably 0.2 to 0.4 mm).
本發明所使用之亞氯酸鹽，例如可列舉出亞氯酸鹼金屬鹽或亞氯酸鹼土類金屬鹽。亞氯酸鹼金屬鹽，例如可列舉出亞氯酸鈉、亞氯酸鉀、亞氯酸鋰，亞氯酸鹼土類金屬鹽，例如可列舉出亞氯酸鈣、亞氯酸鎂、亞氯酸鋇。當中，從容易取得之觀點來看，較佳為亞氯酸鈉、亞氯酸鉀，最佳為亞氯酸鈉。此等亞氯酸鹽可單獨使用1種或併用2種以上。 Examples of the chlorite used in the present invention include alkali metal chlorite or alkaline earth metal chlorite. Examples of alkali metal chlorite salts include sodium chlorite, potassium chlorite, and lithium chlorite. Examples of alkaline earth metal salts of chlorite include calcium chlorite, magnesium chlorite, and chlorite. barium. Among them, from the viewpoint of easy availability, sodium chlorite and potassium chlorite are preferred, and sodium chlorite is most preferred. These chlorites can be used alone or in combination of two or more.
本發明所使用之固形的亞氯酸鹽，可載持於多孔質物質。 The solid chlorite used in the present invention can be carried on a porous substance.
本發明中，將固形的亞氯酸鹽載持於多孔質物質，並在多孔質物質的表面與光反應，藉此，與直接使用固形的亞氯酸鹽之狀態時相比，能夠以較少能量引發反應。亦即，本發明中，藉由將固形的亞氯酸鹽載持於多孔質物質後使用，可更有效率地產生二氧化氯。本發明所使用之多孔質物質，例如可使用海泡石(Sepiolite)、山軟木石(Palygorskite)、蒙特石(Montmorillonite)、二氧化矽凝膠、矽藻土、沸石(Zeolite)、及珍珠岩(Perlite)等，為了不使亞氯酸鹽分解，較佳係在使懸浮於水時顯現出鹼性者，尤佳為山軟木石與 海泡石，特佳為海泡石。 In the present invention, the solid chlorite is supported on the porous substance, and reacts with light on the surface of the porous substance, whereby compared with the state where the solid chlorite is directly used, Less energy triggers the reaction. That is, in the present invention, by supporting solid chlorite on a porous substance and using it, chlorine dioxide can be generated more efficiently. For the porous material used in the present invention, for example, sepiolite, palygorskite, montmorillonite, silica gel, diatomaceous earth, zeolite, and perlite can be used (Perlite), etc., in order not to decompose the chlorite, it is preferred to be alkaline when suspended in water, especially mountain cork stone and Sepiolite, especially sepiolite.
本發明中，將亞氯酸鹽載持於多孔質物質之方法並無特別限定。例如，「載持亞氯酸鹽之多孔質物質」，可將亞氯酸鹽水溶液含浸於多孔質物質並乾燥而得。「載持亞氯酸鹽之多孔質物質」的含水率較佳為10重量%以下，更佳為5重量%以下。 In the present invention, the method of supporting chlorite on a porous substance is not particularly limited. For example, "a porous substance supporting chlorite" can be obtained by impregnating a porous substance with an aqueous solution of chlorite and drying it. The water content of the "porous substance supporting chlorite" is preferably 10% by weight or less, and more preferably 5% by weight or less.
本發明所使用之「載持亞氯酸鹽之多孔質物質」，可使用任意粒徑者，特佳可使用平均粒徑1mm至3mm者。 For the "porous substance carrying chlorite" used in the present invention, any particle size can be used, and particularly those with an average particle size of 1 mm to 3 mm can be used.
本發明之「載持亞氯酸鹽之多孔質物質」的平均粒徑，例如可藉由光學顯微鏡來測定所使用之「載持亞氯酸鹽之多孔質物質」的粒徑，然後進行統計處理並計算平均值與標準差而算出。 The average particle diameter of the "porous substance supporting chlorite" of the present invention can be measured by an optical microscope, for example, and then the statistics Process and calculate the average and standard deviation.
本發明所使用之「載持亞氯酸鹽之多孔質物質」中之亞氯酸鹽的濃度，以1重量%以上者為有效，但因超過25重量%時相當於劇烈物質，故較佳為1重量%以上25重量%以下，尤佳為5重量%以上20重量%以下。 The concentration of chlorite in the "porous substance supporting chlorite" used in the present invention is effective at 1% by weight or more, but when it exceeds 25% by weight, it is equivalent to a violent substance, so it is preferable 1% by weight or more and 25% by weight or less, particularly preferably 5% by weight or more and 20% by weight or less.
本發明所使用之「包含固形的亞氯酸鹽之藥劑」，可進一步包含金屬觸媒或金屬氧化物觸媒。例如，本發明所使用之「包含固形的亞氯酸鹽之藥劑」，可為包含(A)載持亞氯酸鹽之多孔質物質、及(B)金屬觸媒或金屬氧化物觸媒之藥劑。 The "agent containing solid chlorite" used in the present invention may further include a metal catalyst or a metal oxide catalyst. For example, the "medicine containing solid chlorite" used in the present invention may include (A) a porous substance supporting chlorite, and (B) a metal catalyst or a metal oxide catalyst Pharmacy.
本發明所使用之金屬觸媒或金屬氧化物觸媒，例如可列舉出鈀、銣、鎳、鈦、及二氧化鈦。此等當 中，特佳為二氧化鈦。二氧化鈦有時僅稱為氧化鈦或鈦白(Titania)。本發明所使用之金屬觸媒或金屬氧化物觸媒，可使用粉狀、粒狀等各種形態，該業者可藉由藥劑中之亞氯酸鹽與金屬觸媒或金屬氧化物觸媒之混合比率，來選擇適當的較佳形態。例如，藥劑中之金屬觸媒或金屬氧化物觸媒的比率相對較高時，可選擇粒狀金屬觸媒或金屬氧化物觸媒，藥劑中之金屬觸媒或金屬氧化物觸媒的比率相對較低時，可選擇粉狀金屬觸媒或金屬氧化物觸媒，但並不限定於此等。 Examples of the metal catalyst or metal oxide catalyst used in the present invention include palladium, rubidium, nickel, titanium, and titanium dioxide. Equivalent Among them, particularly preferred is titanium dioxide. Titanium dioxide is sometimes just called titanium oxide or titanium dioxide (Titania). The metal catalyst or metal oxide catalyst used in the present invention can be used in various forms such as powder and granules. The manufacturer can mix the chlorite in the drug with the metal catalyst or metal oxide catalyst Ratio to select the appropriate preferred form. For example, when the ratio of metal catalyst or metal oxide catalyst in the agent is relatively high, granular metal catalyst or metal oxide catalyst can be selected, and the ratio of metal catalyst or metal oxide catalyst in the agent is relatively When it is lower, powder metal catalyst or metal oxide catalyst can be selected, but it is not limited to these.
本說明書中，「粉狀」或「粒狀」之大小的大致標準，例如，粉狀是指平均粒徑0.01mm至1mm大小的固形物，粒狀是指平均粒徑1mm至30mm大小的固形物，但並無特別限定。 In this specification, the size of "powder" or "granular" is a general standard. For example, powder refers to solids with an average particle size of 0.01 mm to 1 mm, and granular refers to solids with an average particle size of 1 mm to 30 mm. Thing, but not particularly limited.
本發明所使用之藥劑中之亞氯酸鹽與金屬觸媒或金屬氧化物觸媒之質量比，可為亞氯酸鹽：金屬觸媒或金屬氧化物觸媒=1：0.04至0.8，較佳為1：0.07至0.6，尤佳為1：0.07至0.5。藥劑中，當金屬觸媒或金屬氧化物觸媒含量高於亞氯酸鹽含量的1倍時，以及金屬觸媒或金屬氧化物觸媒含量低於亞氯酸鹽含量的0.04倍時，照射可見光時所產生之亞氯酸鹽的量均可能降低。 The mass ratio of chlorite to metal catalyst or metal oxide catalyst in the agent used in the present invention may be chlorite: metal catalyst or metal oxide catalyst=1: 0.04 to 0.8, compared It is preferably 1:0.07 to 0.6, and particularly preferably 1:0.07 to 0.5. In the agent, when the content of the metal catalyst or metal oxide catalyst is more than 1 times the content of chlorite, and when the content of the metal catalyst or metal oxide catalyst is less than 0.04 times the content of chlorite, irradiation The amount of chlorite produced under visible light may be reduced.
本發明所使用之「載持亞氯酸鹽之多孔質物質」，可更載持鹼劑。 The "porous substance supporting chlorite" used in the present invention can further support an alkali agent.
本發明之藥劑的調製中所使用之鹼劑，例如可使用氫氧化鈉、氫氧化鉀、氫氧化鋰、氫氧化銫、氫 氧化銣、碳酸鈉、碳酸鉀、及碳酸鋰，較佳係使用氫氧化鈉。藉由更將鹼劑載持於「載持亞氯酸鹽之多孔質物質」，可調整本發明所使用之藥劑的pH，提高藥劑本身的穩定性，在未照射光線之保管時等，可抑制二氧化氯的無謂釋出。 As the alkaline agent used in the preparation of the agent of the present invention, for example, sodium hydroxide, potassium hydroxide, lithium hydroxide, cesium hydroxide, and hydrogen can be used Rubidium oxide, sodium carbonate, potassium carbonate, and lithium carbonate are preferably sodium hydroxide. By further supporting the alkaline agent on the "porous substance supporting chlorite", the pH of the agent used in the present invention can be adjusted, the stability of the agent itself can be improved, and it can be stored during storage without light, etc. Suppresses the unnecessary release of chlorine dioxide.
本發明之藥劑的調製中所使用之鹼劑的量，相對於亞氯酸鹽(mol)以0.1當量以上2.0當量以下者為適當，較佳為0.1當量以上1.0當量以下，更佳為0.1當量以上0.7當量以下。未達0.1當量時，所載持之亞氯酸鹽於常溫下亦有分解之疑慮，超過2.0當量時，穩定性雖可提升，但難以產生二氧化氯，使產生濃度降低，故不佳。 The amount of the alkaline agent used in the preparation of the agent of the present invention is suitably 0.1 equivalent or more and 2.0 equivalent or less relative to chlorite (mol), preferably 0.1 equivalent or more and 1.0 equivalent or less, more preferably 0.1 equivalent Above 0.7 equivalent. When it is less than 0.1 equivalent, the contained chlorite may also be decomposed at room temperature. If it exceeds 2.0 equivalent, although the stability can be improved, it is difficult to produce chlorine dioxide, which reduces the concentration and is not good.
本發明之藥劑的調製中，更將鹼劑載持於「載持亞氯酸鹽之多孔質物質」之方法並無特別限定，例如可使用同時或依序將亞氯酸鹽及鹼劑含浸於多孔質物質並乾燥之方法。本說明書中，係藉由將亞氯酸鹽水溶液及/或鹼劑「噴霧吸附」於多孔質物質並乾燥而得到目的組成物，但在本說明書中，用語「噴霧吸附」亦包含於用語「含浸」。 In the preparation of the medicament of the present invention, the method of supporting the alkaline agent on the "porous substance supporting chlorite" is not particularly limited. For example, the chlorite and the alkaline agent can be impregnated simultaneously or sequentially For drying porous materials. In this specification, the target composition is obtained by "spray adsorption" of an aqueous chlorite solution and/or alkaline agent onto a porous substance and drying, but in this specification, the term "spray adsorption" is also included in the term " Impregnation".
本發明，於一實施形態中，可構成為一種具備本發明之二氧化氯產生用單元之二氧化氯產生裝置。本發明之二氧化氯產生裝置，可更具備：將空氣傳送至二氧化氯產生用單元中之容納於藥劑容納部之藥劑之送風部。該送風部可為從裝置的外部將空氣引入於內部之風扇，或是從裝置的內部將空氣釋出至外部之風扇。 The present invention, in one embodiment, can be configured as a chlorine dioxide generating device provided with the chlorine dioxide generating unit of the present invention. The chlorine dioxide generating device of the present invention may further include: an air blowing section that sends air to the medicine contained in the medicine storage section in the chlorine dioxide generating unit. The air supply part may be a fan that introduces air from the outside of the device to the inside, or a fan that releases air from the inside of the device to the outside.
本發明之二氧化氯產生裝置中，將空氣傳送至容納於藥劑容納部之藥劑之送風部，例如可為風扇或空氣泵，但較佳為風扇。藉由具備該送風部，可將更多的空氣供給至藥劑容納部內部的藥劑。藉由將更多的空氣供給至藥劑，可提高包含固形的亞氯酸鹽之藥劑與空氣中的水分(水蒸氣)之接觸頻率，而容易從照射光線後之固形的亞氯酸鹽產生二氧化氯。 In the chlorine dioxide generating device of the present invention, air is sent to the air blowing part of the medicine contained in the medicine containing part, for example, it may be a fan or an air pump, but it is preferably a fan. By providing this air blowing part, more air can be supplied to the medicine inside the medicine storage part. By supplying more air to the agent, the frequency of contact between the agent containing solid chlorite and the moisture (water vapor) in the air can be increased, and it is easy to produce two Chlorine oxide.
本發明之二氧化氯產生裝置中，可藉由前述送風部所送來之空氣，將藥劑容納部中的相對濕度調節於30至80%RH(較佳為40至70%RH，更佳為40至60%RH)。藉由將藥劑容納部中的相對濕度調節於前述範圍，可增加二氧化氯的產生量。 In the chlorine dioxide generating device of the present invention, the relative humidity in the medicine containing section can be adjusted to 30 to 80% RH (preferably 40 to 70% RH, more preferably 40 to 60%RH). By adjusting the relative humidity in the medicine containing portion within the aforementioned range, the amount of chlorine dioxide produced can be increased.
此外，本發明之二氧化氯產生裝置中，將空氣中的水蒸氣供給至藥劑容納部中之其他方法，亦可應用使空氣中的水分凝聚並集中之熱電轉換元件(熱電轉換效應)(亦可反向應用因水蒸氣的侵入或結露所產生之熱電轉換元件的缺點而使濕度上升)。 In addition, in the chlorine dioxide generating device of the present invention, other methods of supplying water vapor in the air to the medicine containing portion can also apply thermoelectric conversion elements (thermoelectric conversion effect) that condense and concentrate moisture in the air (also The reverse application of the disadvantages of thermoelectric conversion elements caused by the intrusion of water vapor or condensation can increase the humidity).
裝置內之相對濕度的控制方法並無特別限定，可使用該業者一般所知的技術適當實施。例如於裝置本體的內部設置測定濕度之濕度計，一邊監看水分量一邊調節來自送風部的送風量，或是調節由熱電轉換元件所進行之吸濕量，來控制相對濕度。 The method of controlling the relative humidity in the device is not particularly limited, and can be suitably implemented using techniques generally known by the industry. For example, a hygrometer for measuring humidity is installed inside the device body, and the amount of air supplied from the blower is adjusted while monitoring the amount of water, or the amount of moisture absorbed by the thermoelectric conversion element is adjusted to control the relative humidity.
此外，由於本發明之二氧化氯產生用單元為小型，故亦可組裝於未以二氧化氯的產生為主要目的之 家電製品等。將本發明之二氧化氯產生用單元組裝於未以二氧化氯的產生為主要目的之家電製品等而成之裝置，亦包含於本發明之「二氧化氯產生裝置」。例如，藉由將本發明之二氧化氯產生用單元組裝於例如暖氣機、冷氣機、空氣清淨機、加濕器等空調設備，可藉由從空調設備所釋出之風的效果，促進二氧化氯產生用單元中二氧化氯的產生，並順著從空調設備釋出至空間之風，將二氧化氯有效率地擴散至空間。 In addition, since the unit for producing chlorine dioxide of the present invention is small, it can also be assembled in a case where the main purpose of the production of chlorine dioxide is not Home appliances, etc. A device in which the unit for generating chlorine dioxide of the present invention is assembled into household electrical appliances and the like whose main purpose is not the generation of chlorine dioxide is also included in the "chlorine dioxide generating device" of the present invention. For example, by assembling the chlorine dioxide generating unit of the present invention into air conditioning equipment such as a heater, air conditioner, air purifier, humidifier, etc., the effect of the wind released from the air conditioning equipment can be The generation of chlorine dioxide in the unit for generating chlorine oxide, along with the wind released from the air-conditioning equipment to the space, effectively diffuses the chlorine dioxide into the space.
本說明書所使用之用語，係用以說明特定實施型態者，並非用以限定本發明。 The terms used in this specification are used to describe specific implementation forms, and are not intended to limit the present invention.
此外，本說明書所使用之「包含」之用語，除了可從文章脈絡中理解其明顯不同者之外，係有意地指出所述事項(構件、步驟、要素或數字等)的存在，且未排除除此之外之事項(構件、步驟、要素或數字等)的存在。 In addition, the term "contains" used in this manual, except that it can be clearly understood from the context of the article, intentionally points out the existence of the mentioned matters (components, steps, elements or numbers, etc.), and does not exclude The existence of other matters (components, steps, elements or numbers, etc.).
在無不同定義下，在此所使用之所有用語(包含技術用語及科學用語)，係具有對本發明之所屬技術的該業者而言被廣泛理解之相同涵義。在此所使用之用語，在未明確表示不同定義下，應解釋為與本說明書及相關技術領域中的涵義具有統合性涵義，而不應解釋為經理想化或過度形式化之涵義。 Without different definitions, all terms (including technical and scientific terms) used herein have the same meanings that are widely understood by those skilled in the art of the present invention. The terminology used here should be interpreted as having an integrated meaning with the meaning in this specification and related technical fields without expressing different definitions, and should not be interpreted as an idealized or excessively formalized meaning.
本發明之實施型態，有時一邊參考示意圖來說明，於示意圖中，為了使說明更加明確，有時會誇張地表現。 The embodiment of the present invention is sometimes explained with reference to the schematic diagram. In the schematic diagram, in order to make the description clearer, it is sometimes exaggerated.
本說明書中，例如表現為「1至10%」時， 對該業者而言可理解為該表現係個別具體地表示1、2、3、4、5、6、7、8、9、或10%。 In this manual, for example, "1 to 10%", For the industry, it can be understood that the performance specifically indicates 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10% individually.
本說明書中，用以表示成分含量或數值範圍之所有數值，在無明確表示下，係解釋為包含用語「約」之涵義。例如，「10倍」，在無明確表示下，可理解為「約10倍」之涵義。 In this specification, all numerical values used to indicate the content of ingredients or numerical ranges are interpreted to include the meaning of the term "about" unless expressly indicated. For example, "10 times" can be understood as the meaning of "about 10 times" without explicit expression.
本說明書中所引用之文獻，應視為此等的所有揭示內容被援引至本說明書中，該業者可依循本說明書的文章脈絡，在不脫離本發明的精神及範圍內，理解為將此等先前技術文獻中的相關揭示內容援引作為本說明書中的一部分。 The documents cited in this specification should be regarded as all of these disclosures are incorporated into this specification, the industry can follow the context of the article in this specification, without departing from the spirit and scope of the present invention, understand this Related disclosures in the prior art literature are cited as part of this specification.
以下係參考實施例來更詳細說明本發明。然而，本發明可藉由各種型態來具體化，不應解釋為受限於在此所述之實施例。 The following is a more detailed description of the present invention with reference to examples. However, the present invention can be embodied by various types and should not be construed as being limited to the embodiments described herein.
實施例1：由照射之光的波長所造成之二氧化氯產生量的變化 Example 1: Change in the amount of chlorine dioxide produced by the wavelength of the irradiated light
本實施例中，係使用第1圖及第2圖所述之二氧化氯產生單元及二氧化氯產生裝置來進行試驗。 In this example, the chlorine dioxide generating unit and the chlorine dioxide generating device described in FIGS. 1 and 2 were used for the test.
第1圖係顯示本實施例所使用之二氧化氯產生用單元之藥劑容納部及光源部的內部構造之縱向剖面圖。如第1圖所示，二氧化氯產生用單元10具備藥劑容納部11及產生可見區域的光之光源部(LED晶片12及操作基板13)。藥劑容納部11包含試驗用藥劑14。藥劑容納部11
以使空氣可在內部與外部移動之方式具備開口部16。二氧化氯產生用單元10具備將裝置外部的空氣導入於裝置內之管15。
FIG. 1 is a longitudinal cross-sectional view showing the internal structure of the chemical storage part and the light source part of the chlorine dioxide generation unit used in this embodiment. As shown in FIG. 1, the chlorine
從管15導入之空氣，通過開口部16被供給至藥劑容納部11的內部。被供給之空氣中所包含的水蒸氣，被納入於試驗用藥劑14中的亞氯酸鹽。由光源部所產生之可見區域的光，穿透藥劑容納部11的底面而照射在存在於藥劑容納部11的內部之試驗用藥劑14。包含水蒸氣之亞氯酸鹽，與所照射之光反應而產生二氧化氯。與亞氯酸鹽一同包含於試驗用藥劑14之二氧化鈦，藉由照射可見區域的光，而促進從亞氯酸鹽產生二氧化氯之反應。所產生之二氧化氯，通過開口部16被排出至外部。
The air introduced from the
第2圖係顯示本實施例所使用之二氧化氯產生裝置的全體構造之縱向剖面圖。如第2圖所示，二氧化氯產生裝置20於內部具備二氧化氯產生用單元21。二氧化氯產生裝置20的裝置本體22，具備：將裝置外部的空氣導入於裝置內部之空氣供給口23、以及將裝置內部的空氣排出至裝置外部之空氣排出口25。此外，二氧化氯產生裝置20，為了有效率地將空氣導入於裝置內部，於內部具備風扇24。
FIG. 2 is a longitudinal cross-sectional view showing the overall structure of the chlorine dioxide generating device used in this example. As shown in FIG. 2, the chlorine
藉由驅動風扇24，從空氣供給口23將空氣導入於裝置本體22的內部。被導入之空氣，通過設置在裝置內部之二氧化氯產生用單元21，從空氣排出口25排出。二氧化氯產生用單元21中，藉由與第1圖所述之裝置相同
的機制來產生二氧化氯，所以從空氣排出口25排出之空氣中包含二氧化氯。
By driving the
使10wt%亞氯酸鈉水溶液70g噴霧吸附於100g的海泡石並乾燥後，再使10wt%氫氧化鈉水溶液20g噴霧吸附並乾燥。然後將對鈦粉末施以燒結處理所調製之粉狀二氧化鈦20g混合於此，而構成本實施例所使用之試驗用藥劑。 After 70 g of 10 wt% sodium chlorite aqueous solution was spray-adsorbed to 100 g of sepiolite and dried, 20 g of 10 wt% sodium hydroxide aqueous solution was spray-adsorbed and dried. Then, 20 g of powdered titanium dioxide prepared by subjecting the titanium powder to sintering treatment was mixed to constitute the test agent used in this example.
於第2圖所述之二氧化氯產生裝置的藥劑容納部中，容納上述藥劑。以1L/min從藥劑容納部的開口部將空氣導入於藥劑容納部內，並從LED晶片將光照射在藥劑容納部內的藥劑。從LED晶片所照射之光的波長，於80nm至430nm間每次改變2nm，並測定從二氧化氯產生裝置所排出之空氣中所包含之二氧化氯濃度及臭氧濃度。本實施例，係將二氧化氯產生裝置收納於約7公升的反應室內來進行，二氧化氯濃度及臭氧濃度的測定，係藉由測定該反應室內的二氧化氯濃度及臭氧濃度來進行。該結果如第3圖及第4圖所示。本試驗中，係使用頻率計數器(MCA3000、Tektronix公司)、光譜分析儀(BSA、Agilent Technology公司)、波長掃描光源(TSL-510、Suntec公司)、紫外線積算光量計(UIT-250、Ushio電機公司)、以及紫外線積算光量計感光器(VUV-S172、UVD-C405、Ushio電機公司)。 The chemical storage part of the chlorine dioxide generating device shown in FIG. 2 contains the chemical. At 1 L/min, air is introduced into the medicine storage portion from the opening of the medicine storage portion, and the medicine in the medicine storage portion is irradiated with light from the LED wafer. The wavelength of the light irradiated from the LED chip is changed by 2 nm each time between 80 nm and 430 nm, and the concentration of chlorine dioxide and ozone contained in the air discharged from the chlorine dioxide generating device are measured. In this embodiment, the chlorine dioxide generating device is housed in a reaction chamber of approximately 7 liters. The measurement of the chlorine dioxide concentration and the ozone concentration is performed by measuring the chlorine dioxide concentration and the ozone concentration in the reaction chamber. The results are shown in Figures 3 and 4. In this test, a frequency counter (MCA3000, Tektronix Corporation), a spectrum analyzer (BSA, Agilent Technology Corporation), a wavelength scanning light source (TSL-510, Suntec Corporation), an ultraviolet integrated light meter (UIT-250, Ushio Motor Corporation) ), and ultraviolet photometric photometer photoreceptor (VUV-S172, UVD-C405, Ushio Motor Company).
第3圖係顯示於各種光的波長時之空氣中的二氧化氯濃度及臭氧濃度的實測值之圖表，第4圖為上 述測定值中，比較紫外區域(80至358nm)中之測定值的平均值與可見區域(360至430nm)中之測定值的平均值之圖表。第4圖中，紫外區域及可見區域中二氧化氯之測定值的平均值分別約為2.25ppm、4.87ppm，紫外區域及可見區域中臭氧之測定值的平均值分別約為7.04ppm、3.04ppm。 Figure 3 is a graph showing the measured values of chlorine dioxide concentration and ozone concentration in the air at various wavelengths of light, and Figure 4 is the top Among the measured values, a graph comparing the average value of the measured values in the ultraviolet region (80 to 358 nm) with the average value of the measured values in the visible region (360 to 430 nm). In Figure 4, the average value of the measured values of chlorine dioxide in the ultraviolet region and visible region are about 2.25ppm and 4.87ppm, and the average value of the measured values of ozone in the ultraviolet region and visible region are about 7.04ppm and 3.04ppm, respectively .
如第3圖所示，將照射在藥劑之光的波長從紫外區域朝可見區域移動時，空氣中的臭氧濃度於紫外區域中成為極大，並隨著從紫外區域朝可見區域而減少。另一方面，令人驚訝的是，空氣中的二氧化氯濃度隨著從紫外區域朝可見區域而上升。從該結果，對於該業者而言可理解的是，本發明可適合使用之波長範圍，即使超過本實施例之測定範圍的上限之430nm，例如至少在約450nm的波長中，亦無問題可使用。 As shown in Fig. 3, when the wavelength of the light irradiated on the medicine is moved from the ultraviolet region to the visible region, the ozone concentration in the air becomes maximum in the ultraviolet region and decreases as it moves from the ultraviolet region to the visible region. On the other hand, it is surprising that the concentration of chlorine dioxide in the air increases from the ultraviolet region to the visible region. From this result, it is understandable to the industry that the wavelength range in which the present invention can be suitably used, even if it exceeds 430 nm of the upper limit of the measurement range of this embodiment, for example, at least in the wavelength of about 450 nm, can be used without problems .
再者，如第4圖所示，當比較紫外區域與可見區域中之空氣中的臭氧濃度及二氧化氯濃度之各別平均值時，臭氧濃度從紫外區域朝可見區域減少至約43%，相對於此，二氧化氯濃度從紫外區域朝可見區域上升至約213%。 Furthermore, as shown in Figure 4, when comparing the average values of ozone concentration and chlorine dioxide concentration in the air in the ultraviolet region and the visible region, the ozone concentration decreases from the ultraviolet region to the visible region to about 43%, In contrast, the concentration of chlorine dioxide increased from the ultraviolet region to the visible region to about 213%.
亦即，藉由將可見區域的光照射在固形的亞氯酸鹽及金屬觸媒或金屬氧化物觸媒之混合物，與照射紫外區域的光者相比，能夠極有效率地產生二氧化氯。 That is, by irradiating light in the visible region on a mixture of solid chlorite and a metal catalyst or metal oxide catalyst, chlorine dioxide can be produced very efficiently compared to those irradiating light in the ultraviolet region .
實施例2：由觸媒的形狀所造成之二氧化氯產生量的變化 Example 2: Change in the amount of chlorine dioxide produced by the shape of the catalyst
本實施例所使用之樣本1中，除了使用粒狀二氧化鈦
(對鈦施以燒結處理所調製者)之外，其他以與實施例1相同之方法來調製藥劑。本實施例所使用之樣本2及3中，以與實施例1相同之方法來調製藥劑。
In
將藉由上述方法所調製之藥劑(樣本1至3)，分別容納於實施例1所述之二氧化氯產生裝置的藥劑容納部。關於樣本1及樣本2，以1L/min從藥劑容納部的開口部將空氣導入於裝置內，並從光源部的LED晶片照射405nm的光。關於樣本3，僅以1L/min從藥劑容納部的開口部將空氣導入於裝置內，並未照射光線。然後測定從照射開始至11小時後為止之從裝置排出之空氣中所包含之二氧化氯濃度。第5圖係顯示樣本1至3的各別測定結果。
The medicines (
如第5圖所示，於藥劑中混合粒狀二氧化鈦(樣本1)時，與於藥劑中混合粉狀二氧化鈦(樣本2)時相比，可得知能夠更有效率地產生二氧化氯。 As shown in FIG. 5, when granular titanium dioxide (Sample 1) was mixed with the drug, it was found that chlorine dioxide could be generated more efficiently than when powdered titanium dioxide (Sample 2) was mixed with the drug.
實施例3：關於藥劑中之亞氯酸鹽與二氧化鈦的含有比率之探討 Example 3: Discussion on the content ratio of chlorite and titanium dioxide in pharmaceuticals
使10wt%亞氯酸鈉水溶液70g噴霧吸附於100g的海泡石並乾燥後，再使10wt%氫氧化鈉水溶液20g噴霧吸附並乾燥。然後改變粉狀二氧化鈦的量並混合於此，而構成本實施例所使用之試驗用藥劑。對試驗用藥劑之可見光的照射，係以與實施例1相同的二氧化氯產生裝置及照射方法來進行。 After 70 g of 10 wt% sodium chlorite aqueous solution was spray-adsorbed to 100 g of sepiolite and dried, 20 g of 10 wt% sodium hydroxide aqueous solution was spray-adsorbed and dried. Then, the amount of powdered titanium dioxide was changed and mixed therein to constitute the test agent used in this example. The irradiation of the visible light of the test agent was performed using the same chlorine dioxide generator and irradiation method as in Example 1.
第6圖係顯示改變本發明之組成物中之亞氯酸鹽與二氧化鈦的比率時之二氧化氯產生量的變化。第
6圖中所示之藥劑中之二氧化鈦含量(wt%)、藥劑中之亞氯酸鹽與二氧化鈦的質量比、以及開始照射可見光1小時後空氣中所包含之二氧化氯濃度(ppm)之關係，係如第1表所示。此外，第7圖係顯示本發明之藥劑中之二氧化鈦含量與因照射可見光所產生之二氧化氯濃度的最大值之關係。
Figure 6 shows the change in the amount of chlorine dioxide produced when the ratio of chlorite to titanium dioxide in the composition of the present invention is changed. First
6 The relationship between the content of titanium dioxide in the agent (wt%), the mass ratio of chlorite to titanium dioxide in the agent, and the concentration of chlorine dioxide (ppm) in the
如第6圖、第7圖、第1表所示，將可見光照射在試驗用藥劑時所產生二氧化氯的量，隨著藥劑中之二氧化鈦相對於亞氯酸鹽之質量比率從0增加至約0.3而上升，當二氧化鈦相對於亞氯酸鹽之質量比率超過約0.3時，則緩慢減少。此外，當組成物中之二氧化鈦相對於亞氯酸鹽之質量比率超過約1.0時，與不混合二氧化鈦時相 比，二氧化氯的產生量減少。 As shown in Figure 6, Figure 7, and Table 1, the amount of chlorine dioxide generated when the visible light is irradiated to the test agent increases as the mass ratio of titanium dioxide to the chlorite in the agent increases from 0 to It increases by about 0.3, and when the mass ratio of titanium dioxide to chlorite exceeds about 0.3, it slowly decreases. In addition, when the mass ratio of titanium dioxide to chlorite in the composition exceeds about 1.0, the phase Compared, the production of chlorine dioxide is reduced.
第8圖係顯示將可見光長時間持續照射在本實施例之試驗用藥劑時之二氧化氯產生量變化之圖。如第8圖所示，即使涵蓋長時間來觀察，亦與第6圖或第7圖所示之結果相同，將試驗用藥劑中之亞氯酸鹽與二氧化鈦的混合比率(質量比)設為1：0.04至0.8(較佳為1：0.07至0.6，更佳為1：0.07至0.5)時，與將混合比率設為該範圍以外時相比，確認可穩定持續釋出高濃度的二氧化氯。 Fig. 8 is a graph showing the change in the amount of chlorine dioxide produced when the visible light is continuously irradiated to the test agent of this example. As shown in Fig. 8, even if observed over a long period of time, it is the same as the result shown in Fig. 6 or Fig. 7, and the mixing ratio (mass ratio) of chlorite and titanium dioxide in the test agent is set to 1:0.04 to 0.8 (preferably 1:0.07 to 0.6, more preferably 1:0.07 to 0.5), compared to when the mixing ratio is outside this range, it is confirmed that a high concentration of dioxide can be stably and continuously released chlorine.
實施例4：對於光源部的三明治構造之探討 Example 4: Discussion on the sandwich structure of the light source
本發明中，對於光源部的三明治構造之有效性進行試驗。本實施例中，係使用第9圖所述之二氧化氯產生用單元以及第10圖所述之二氧化氯產生裝置進行實驗。 In the present invention, the effectiveness of the sandwich structure of the light source is tested. In this example, experiments were performed using the chlorine dioxide generation unit described in FIG. 9 and the chlorine dioxide generation device described in FIG. 10.
第9圖係顯示本發明的一實施形態之二氧化氯產生用單元30的內部構造之圖。如第9圖所示，本發明之二氧化氯產生用單元30，具備藥劑容納部32及產生可見區域的光之光源部(電子基板33及LED晶片34)。藥劑容納部32於內部含有包含固形的亞氯酸鹽之藥劑。藥劑容納部32以使空氣可在內部與外部移動之方式具備開口部(氣體產生口31、空氣導入口36)。
FIG. 9 is a diagram showing the internal structure of the chlorine
從空氣導入口36導入之空氣，被供給至藥劑容納部32的內部。被供給之空氣中所包含的水蒸氣，被納入於藥劑容納部32中所容納之試驗用藥劑。由光源部所產生之可見區域的光，穿透藥劑容納部32的外裝部35而照射在容納於藥劑容納部32的內部之藥劑。包含水蒸氣之
試驗用藥劑，與所照射之光反應而產生二氧化氯。所產生之二氧化氯，通過氣體產生口31被排出至外部。
The air introduced from the
第10圖係顯示本發明的一實施形態之二氧化氯產生裝置40的內部構造之圖。如第10圖所示，本發明之二氧化氯產生裝置40，於內部具備本發明的一實施形態之二氧化氯產生用單元(LED晶片裝著基板41、及藥劑容納部42)。二氧化氯產生裝置，於內部更具備送風風扇44，藉由驅動送風風扇44，將空氣供給至二氧化氯產生用單元內部。藉由調節送風風扇44的驅動，可調節二氧化氯產生用單元中之藥劑容納部內的相對濕度。
Fig. 10 is a diagram showing the internal structure of a
藉由驅動送風風扇44，從二氧化氯產生用單元的空氣導入口將空氣導入於藥劑容納部的內部。被供給之空氣中所包含的水蒸氣，被納入於藥劑容納部中所容納之試驗用藥劑。由光源部所產生之可見區域的光，穿透藥劑容納部的外裝部而照射在容納於藥劑容納部的內部之藥劑。包含水蒸氣之試驗用藥劑，與所照射之光反應而產生二氧化氯。所產生之二氧化氯，通過氣體產生口被排出至外部。
By driving the
使10wt%亞氯酸鈉水溶液70g噴霧吸附於100g的海泡石並乾燥後，再使10wt%氫氧化鈉水溶液20g噴霧吸附並乾燥。然後將粉狀二氧化鈦約1.8g混合於此，而構成本實施例所使用之試驗用藥劑。將調製出之試驗用藥劑，容納於第9圖所述之二氧化氯產生用單元的藥劑容納部，並從2面的光源部(分別為100mm2)照射可見光。本 試驗係於1m3的反應室內進行，反應室內的溫度約26℃，相對濕度約40%。比較例中，除了將1面(單面)的光源部使用在可見光的照射之外，其他與實施例相同地進行試驗。 After 70 g of a 10 wt% sodium chlorite aqueous solution was spray-adsorbed to 100 g of sepiolite and dried, 20 g of a 10 wt% sodium hydroxide aqueous solution was spray-adsorbed and dried. Then, about 1.8 g of powdery titanium dioxide was mixed here to constitute the test agent used in this example. The prepared test drug was accommodated in the drug storage part of the chlorine dioxide generation unit described in FIG. 9 and visible light was irradiated from the light source part (100 mm 2 each ) on both sides. This test is carried out in a 1m 3 reaction chamber. The temperature in the reaction chamber is about 26°C and the relative humidity is about 40%. In the comparative example, the test was carried out in the same manner as in the example, except that one side (single side) light source was used for irradiation of visible light.
第11圖係顯示於實施例及比較例中，測定反應室內之二氧化氯濃度的經時變化之結果。此外，第12圖係顯示從照射開始的各別時間中，於實施例及比較例中之反應室內二氧化氯濃度的比。第12圖中，從2個光源部(雙面)照射光線時，與僅從1個光源部(單面)照射光線時相比，為了顯示二氧化氯的產生量成為2倍以上，取得二氧化氯產生量的比時係採用單面照射時二氧化氯產生量的2倍值。 Figure 11 shows the results of measuring the changes in the concentration of chlorine dioxide over time in the reaction chamber in the examples and comparative examples. In addition, Fig. 12 shows the ratio of the concentration of chlorine dioxide in the reaction chambers in the examples and comparative examples at various times from the start of irradiation. In FIG. 12, when light is irradiated from two light source parts (double-sided), compared with when light is irradiated from only one light source part (single-sided), in order to show that the amount of generated chlorine dioxide is more than doubled, the The ratio of the amount of chlorine oxide produced is a value twice that of the amount of chlorine dioxide produced when irradiated on one side.
如第11圖及第12圖所示，從2個光源部(雙面)照射可見光時，令人驚訝的是與僅從1個光源部(單面)照射可見光時相比，顯示二氧化氯的產生量成為2倍以上。此外，如第12圖所示，亦顯示實施例的二氧化氯產生量相對於比較例的二氧化氯產生量之比值，隨著時間經過而進一步上升。 As shown in Fig. 11 and Fig. 12, when visible light is irradiated from two light source parts (both sides), surprisingly, compared with when only one light source part (single side) is irradiated with visible light, it shows chlorine dioxide The amount of production has more than doubled. In addition, as shown in FIG. 12, it is also shown that the ratio of the amount of chlorine dioxide generated in the example to the amount of chlorine dioxide generated in the comparative example further increases with time.
藉由第13圖可說明上述結果。亦即，當光通過介質中時光強度呈指數函數性地減少，所以在僅從單面照射時，光不易到達藥劑的內部或深處，難以有效率地將光照射在藥劑全體。然而，從2方向(或2個以上的方向)將光照射在藥劑，可將反應所需量的光供給至藥劑的內部，而能夠有效率地產生二氧化氯。 The above results can be illustrated by Figure 13. That is, when the light passes through the medium, the light intensity decreases exponentially. Therefore, when the light is irradiated from only one side, the light does not easily reach the inside or the depth of the medicine, and it is difficult to efficiently irradiate the light to the entire medicine. However, by irradiating light on the drug from two directions (or two or more directions), the amount of light required for the reaction can be supplied to the inside of the drug, and chlorine dioxide can be efficiently produced.
實施例5：對於藥劑容納部的相對濕度之探 討 Example 5: Probe into the relative humidity of the medicine containing part discuss
使用第9圖所述之二氧化氯產生用單元以及第10圖所述之二氧化氯產生裝置，對於由藥劑容納部的相對濕度所造成之二氧化氯產生量的變化進行探討。 Using the chlorine dioxide generation unit shown in FIG. 9 and the chlorine dioxide generation device shown in FIG. 10, the change in the amount of chlorine dioxide generated due to the relative humidity of the drug storage section will be discussed.
關於容納於藥劑容納部之藥劑、可見光的照射方法、及二氧化氯濃度的測定，係使用與實施例4相同之條件。藥劑容納部內的相對濕度，可藉由驅動送風風扇，控制供給至藥劑容納部之空氣的量(亦即供給至藥劑容納部之水蒸氣的量)來調節。藥劑容納部內的相對濕度與反應室內的二氧化氯濃度之關係，係如第14圖及第15圖所示。第14圖係顯示將從0.5小時至2小時的光照射中測定複數次之二氧化氯濃度進行平均後之值及其標準差，第15圖係顯示反應室內的二氧化氯濃度隨時間之變化。 Regarding the medicine contained in the medicine storage part, the method of irradiating visible light, and the measurement of the concentration of chlorine dioxide, the same conditions as in Example 4 were used. The relative humidity in the medicine storage section can be adjusted by driving the blower fan to control the amount of air supplied to the medicine storage section (that is, the amount of water vapor supplied to the medicine storage section). The relationship between the relative humidity in the drug container and the concentration of chlorine dioxide in the reaction chamber is shown in Figure 14 and Figure 15. Figure 14 shows the value and standard deviation of chlorine dioxide concentration measured from multiple times of light irradiation from 0.5 hours to 2 hours and averaged. Figure 15 shows the change of chlorine dioxide concentration in the reaction chamber with time .
如第14圖所示，藉由將藥劑容納部內的相對濕度調節於30至80%RH(較佳為50至70%RH，更佳為40至60%RH)，可增加二氧化氯的產生量。藥劑容納部內的相對濕度未達30%RH時，從亞氯酸鹽產生二氧化氯之反應中的所需水分不足，相對濕度高於80%RH時，所產生之二氧化氯會溶入於結露的水中，使以氣體釋出之二氧化氯的量減少。 As shown in FIG. 14, by adjusting the relative humidity in the medicine containing portion to 30 to 80% RH (preferably 50 to 70% RH, more preferably 40 to 60% RH), the production of chlorine dioxide can be increased the amount. When the relative humidity in the medicinal container is less than 30%RH, the required moisture in the reaction to generate chlorine dioxide from chlorite is insufficient. When the relative humidity is higher than 80%RH, the generated chlorine dioxide will be dissolved in Condensed water reduces the amount of chlorine dioxide released as a gas.
此外，如第15圖所示，藉由將藥劑容納部內的相對濕度調節於30至80%RH(較佳為40至70%RH，更佳為40至60%RH)，與相對濕度未達30%RH時相比，從照射開始隨著時間的經過，可維持較高之釋出二氧化氯濃 度。即使將相對濕度設為20%，照射開始初期的二氧化氯濃度昇高，可考量為照射開始前的藥劑本身含有某種程度的水分之故。 In addition, as shown in FIG. 15, by adjusting the relative humidity in the medicine containing portion to 30 to 80% RH (preferably 40 to 70% RH, more preferably 40 to 60% RH), the relative humidity is less than Compared with 30%RH, it can maintain a high concentration of released chlorine dioxide over time from the beginning of irradiation degree. Even if the relative humidity is set to 20%, the concentration of chlorine dioxide at the beginning of the irradiation increases, which may be considered because the drug itself before the irradiation starts contains a certain amount of moisture.
實施例6：對於間歇照射的有用性之探討 Example 6: Discussion on the usefulness of intermittent irradiation
使用第9圖之二氧化氯產生用單元，在本發明中進行可見光間歇照射之有用性檢討。 Using the unit for chlorine dioxide generation in FIG. 9, the usefulness of intermittent visible light irradiation was examined in the present invention.
關於容納於藥劑容納部之藥劑、及二氧化氯濃度的測定，係使用與實施例4相同之條件。來自光源部之可見光的間歇照射，係藉由切換LED的開啟/關閉來交互進行可見光的照射及停止而實施。具體而言，係以下述(1)至(3)的條件進行間歇照射。 Regarding the measurement of the drug contained in the drug storage part and the concentration of chlorine dioxide, the same conditions as in Example 4 were used. The intermittent irradiation of visible light from the light source unit is implemented by switching on/off of the LED to alternately irradiate and stop visible light. Specifically, the intermittent irradiation is performed under the following conditions (1) to (3).
(1)照射開始2分鐘內持續照射光線，照射開始2分鐘後重複進行照射光線10秒(開啟LED)、停止照射光線80秒(關閉LED)之循環。 (1) Continue to irradiate the light for 2 minutes after the start of irradiation. Repeat the cycle of irradiating the light for 10 seconds (turn on the LED) and stop the light for 80 seconds (turn off the LED) after 2 minutes.
(2)照射開始2分鐘內持續照射光線，照射開始2分鐘後重複進行照射光線20秒(開啟LED)、停止照射光線80秒(關閉LED)之循環。 (2) Continue to irradiate the light for 2 minutes after the start of irradiation. Repeat the cycle of irradiating the light for 20 seconds (turn on the LED) and stop the light for 80 seconds (turn off the LED) after 2 minutes.
(3)照射開始2分鐘內持續照射光線，照射開始2分鐘後重複進行照射光線30秒(開啟LED)、停止照射光線80秒(關閉LED)之循環。 (3) Continue to irradiate the light for 2 minutes after the start of irradiation. Repeat the cycle of irradiating the light for 30 seconds (turn on the LED) and stop the light for 80 seconds (turn off the LED) after 2 minutes.
本試驗的結果如第16圖所示。第16圖的圖表中之「相對ClO2氣體濃度」，係表示將照射開始的2分鐘後的二氧化氯濃度設為1時之各別時間中之二氧化氯濃度的相對值。
The results of this test are shown in Figure 16. The "relative ClO 2 gas concentration" in the graph of FIG. 16 represents the relative value of the chlorine dioxide concentration at various times when the
如第16圖所示，本發明中，藉由從光源部間歇性地照射可見光，並調節該間歇照射之照射時間與停止時間的均衡，可產生期望濃度的二氧化氯。 As shown in FIG. 16, in the present invention, by intermittently irradiating visible light from the light source section, and adjusting the balance between the irradiation time and the stop time of the intermittent irradiation, chlorine dioxide of a desired concentration can be generated.
此外，本發明中，藉由從光源部間歇性地照射可見光，可防止於照射開始初期釋出相對較高濃度的二氧化氯。當從光源部持續照射可見光(亦即不進行間歇照射)時，例如第6圖的圖表般，於照射開始初期二氧化氯產生濃度極大，然後逐漸衰減。亦即，本發明中，藉由從光源部間歇性地照射可見光，可更穩定地釋出二氧化氯。 In addition, in the present invention, by intermittently irradiating visible light from the light source section, it is possible to prevent the release of chlorine dioxide at a relatively high concentration at the initial stage of irradiation. When visible light is continuously irradiated from the light source section (that is, intermittent irradiation is not performed), for example, as shown in the graph of FIG. 6, the concentration of chlorine dioxide generated at the beginning of the irradiation is extremely large, and then gradually attenuates. That is, in the present invention, by intermittently irradiating visible light from the light source section, chlorine dioxide can be released more stably.
當然，從光源部間歇性地照射可見光時，與從光源部持續照射可見光時相比，可抑制二氧化氯的供給源之包含固形的亞氯酸鹽之藥劑的消耗量。亦即，本發明中，藉由使用可間歇性地照射可見光之光源，可延長二氧化氯產生用單元的可使用期間。 Of course, when the visible light is intermittently irradiated from the light source section, compared with when the visible light is continuously irradiated from the light source section, the consumption amount of the solid chlorite-containing drug consumption source of the chlorine dioxide can be suppressed. That is, in the present invention, by using a light source that can irradiate visible light intermittently, the usable period of the unit for generating chlorine dioxide can be extended.
實施例7：藥劑容納部中通氣性薄片的使用之探討1
Example 7: Discussion on the use of the breathable sheet in the
於本發明的二氧化氯產生裝置中，例如如第10圖所載，為了對藥劑容納部中所容納之固形的藥劑供給水分(水蒸氣)及/或更廣範圍地擴散二氧化氯氣體，係藉由送風風扇向藥劑容納部主動地送入空氣。然而，依著送至藥劑容納部的風量或空氣的濕度等，藥劑有時會過度乾燥，使二氧化氯的產生效率降低，或藥劑變得過度濕潤之虞。 In the chlorine dioxide generating device of the present invention, for example, as shown in FIG. 10, in order to supply moisture (water vapor) to the solid medicine contained in the medicine containing section and/or to diffuse chlorine dioxide gas in a wider range, The air is actively sent into the medicine containing part by the blower fan. However, depending on the amount of air sent to the medicine storage section or the humidity of the air, the medicine may be excessively dried, which may reduce the efficiency of chlorine dioxide generation, or the medicine may become excessively wet.
在此，如第17圖所示，作為於藥劑容納部的開口部覆蓋有通氣性薄片(於本實施例中係使用EXEPOL (註冊商標)(三菱樹脂公司製))之構造，嘗試驅動本發明的二氧化氯產生裝置之實驗。其結果，藉由送入至本發明之裝置中的空氣的大部分係以拂掃藥劑容納部的表面的方式流動，只有一部分係於藥劑容納部的內外來回移動，而可不受到送入至藥劑容納部的風量或空氣的濕度的變化影響，使固形的藥劑之狀態安定化。亦即，藉由使用通氣性薄片，可維持本發明之裝置的二氧化氯擴散能力，並且使二氧化氯之產生效率安定化(第18圖)。進一步地，藥劑容納部的開口部藉由覆蓋通氣性薄片，縱使送入的空氣力道強，藥劑亦不會翻出至藥劑容納部之外，可更加提高裝置的實用性。 Here, as shown in FIG. 17, the opening of the medicine storage portion is covered with a breathable sheet (EXEPOL is used in this embodiment (Registered trademark) (manufactured by Mitsubishi Resin Co., Ltd.)), an experiment to drive the chlorine dioxide generator of the present invention was attempted. As a result, most of the air sent into the device of the present invention flows in such a way as to sweep the surface of the medicine containing part, and only a part is moved back and forth inside and outside the medicine containing part without being fed to the medicine The change of the air volume or the humidity of the air in the accommodating part stabilizes the state of the solid medicine. That is, by using the breathable sheet, the chlorine dioxide diffusion ability of the device of the present invention can be maintained, and the production efficiency of chlorine dioxide can be stabilized (Figure 18). Further, the opening of the medicine containing part is covered with a breathable sheet, and even if the air force sent is strong, the medicine will not be turned out of the medicine containing part, which can further improve the practicality of the device.
實施例8：對於藥劑容納部中通氣性薄片的使用之探討2
Example 8: Exploring the use of breathable sheets in the
於上述的實施例7中，使用不織布(ELEVES(註冊商標，由尼帝佳公司製))作為通氣性薄片，進行相同的實驗。其結果，藉由送入至本發明之裝置中的空氣的大部分係以拂掃藥劑容納部的表面的方式流動，只有一部分係於藥劑容納部的內外來回移動，而可不受到送入至藥劑容納部的風量或空氣的濕度的變化影響，使固形的藥劑之狀態安定化。亦即，藉由使用不織布，可維持本發明之裝置的二氧化氯擴散能力，並且使二氧化氯之產生效率安定化(第18圖)。進一步地，藥劑容納部的開口部藉由覆蓋不織布，縱使送入的空氣力道強，藥劑亦不會翻出至藥劑容納部之外，可更加提高裝置的實用性。 In Example 7 described above, a non-woven fabric (ELEVES (registered trademark, manufactured by Nidijia)) was used as the breathable sheet, and the same experiment was conducted. As a result, most of the air sent into the device of the present invention flows in such a way as to sweep the surface of the medicine containing part, and only a part is moved back and forth inside and outside the medicine containing part without being fed to the medicine The change of the air volume or the humidity of the air in the accommodating part stabilizes the state of the solid medicine. That is, by using a non-woven fabric, the chlorine dioxide diffusion ability of the device of the present invention can be maintained, and the production efficiency of chlorine dioxide can be stabilized (Figure 18). Further, by covering the opening of the medicine containing portion with a non-woven fabric, even if the air force sent in is strong, the medicine will not be turned out of the medicine containing portion, which can further improve the practicality of the device.
10‧‧‧二氧化氯產生用單元 10‧‧‧ Chlorine dioxide production unit
11‧‧‧藥劑容納部 11‧‧‧Pharmaceutical Department
12‧‧‧LED晶片 12‧‧‧LED chip
13‧‧‧操作基板 13‧‧‧Operation board
14‧‧‧藥劑 14‧‧‧Pharmacy
15‧‧‧管 15‧‧‧ tube
16‧‧‧開口部 16‧‧‧Opening
Claims (18)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015-113005 | 2015-06-03 | ||
| JP2015113005 | 2015-06-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201700398A TW201700398A (en) | 2017-01-01 |
| TWI687370B true TWI687370B (en) | 2020-03-11 |
Family
ID=57441231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW105116600A TWI687370B (en) | 2015-06-03 | 2016-05-27 | Chlorine dioxide producing unit and chlorine dioxide producing apparatus |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP6684786B2 (en) |
| KR (1) | KR102584364B1 (en) |
| CN (2) | CN106241741B (en) |
| TW (1) | TWI687370B (en) |
| WO (1) | WO2016194883A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI687370B (en) * | 2015-06-03 | 2020-03-11 | 日商大幸藥品股份有限公司 | Chlorine dioxide producing unit and chlorine dioxide producing apparatus |
| CN107062496B (en) * | 2017-01-15 | 2022-01-28 | 广东德尔玛科技股份有限公司 | Humidifier with purifier |
| JP7045036B2 (en) * | 2018-04-03 | 2022-03-31 | 株式会社アントレックス | Gas generator |
| CN108782552A (en) * | 2018-08-09 | 2018-11-13 | 中昊(大连)化工研究设计院有限公司 | The new process for producing of chlorine dioxide slow-release piece |
| EP4023328A4 (en) * | 2019-10-01 | 2023-12-13 | Acenet Inc. | Radical manufacturing method, spore sterilization method, and cancer treatment drug |
| CN111345315B (en) * | 2020-03-06 | 2021-12-14 | 天津清科环保科技有限公司 | Electrostatic self-assembly slow-release chlorine dioxide air purification gel, preparation method and application |
| KR102373424B1 (en) * | 2020-04-13 | 2022-03-11 | 이명오 | Autonomous driving space sterilization robot for indoor space prevention |
| KR102413976B1 (en) * | 2020-04-13 | 2022-06-27 | 이명오 | Portable space sterilizer using chlorine dioxide gas |
| CN118524988A (en) * | 2022-01-13 | 2024-08-20 | 大幸药品株式会社 | Chlorine dioxide generator |
| CN114992977B (en) * | 2022-07-14 | 2023-04-18 | 长虹美菱股份有限公司 | Refrigerator fresh-keeping control method and device |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1355768A (en) * | 1999-05-18 | 2002-06-26 | 西南研究院 | Energy-activated compositions for controlled sustained release of gas |
| TW201201873A (en) * | 2010-03-26 | 2012-01-16 | Taiko Pharmaceutical Co Ltd | Device for generating chlorine dioxide |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101195477A (en) * | 1999-05-18 | 2008-06-11 | 西南研究院 | Energy-activated compositions for controlled sustained release of a gas |
| JP2005224386A (en) | 2004-02-12 | 2005-08-25 | Daiichi Seidenki Kk | Apparatus for chlorine dioxide gas sterilization |
| JP2012011028A (en) * | 2010-07-01 | 2012-01-19 | Yoshinori Matsuyama | Slowly releasing implement for chlorine dioxide gas |
| JP2012036072A (en) * | 2010-08-09 | 2012-02-23 | Cleancare Inc | Product shape and component composition of chlorine dioxide generator at using time |
| JP2012111673A (en) * | 2010-11-25 | 2012-06-14 | Cleancare Inc | Composition of visible light responsive chlorine dioxide generator and chlorine dioxide releasing product based on the composition |
| MY161353A (en) * | 2011-03-23 | 2017-04-14 | Taiko Pharmaceutical Co Ltd | Chlorine dioxide generator |
| TWI687370B (en) * | 2015-06-03 | 2020-03-11 | 日商大幸藥品股份有限公司 | Chlorine dioxide producing unit and chlorine dioxide producing apparatus |
-
2016
- 2016-05-27 TW TW105116600A patent/TWI687370B/en active
- 2016-05-31 KR KR1020177033259A patent/KR102584364B1/en active IP Right Grant
- 2016-05-31 JP JP2017521943A patent/JP6684786B2/en active Active
- 2016-05-31 WO PCT/JP2016/065948 patent/WO2016194883A1/en active Application Filing
- 2016-06-03 CN CN201610390759.4A patent/CN106241741B/en active Active
- 2016-06-03 CN CN201620537048.0U patent/CN205773321U/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1355768A (en) * | 1999-05-18 | 2002-06-26 | 西南研究院 | Energy-activated compositions for controlled sustained release of gas |
| TW201201873A (en) * | 2010-03-26 | 2012-01-16 | Taiko Pharmaceutical Co Ltd | Device for generating chlorine dioxide |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201700398A (en) | 2017-01-01 |
| WO2016194883A1 (en) | 2016-12-08 |
| JPWO2016194883A1 (en) | 2018-04-19 |
| CN106241741A (en) | 2016-12-21 |
| CN205773321U (en) | 2016-12-07 |
| JP6684786B2 (en) | 2020-04-22 |
| KR20180013886A (en) | 2018-02-07 |
| KR102584364B1 (en) | 2023-10-04 |
| CN106241741B (en) | 2020-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI687370B (en) | Chlorine dioxide producing unit and chlorine dioxide producing apparatus | |
| TWI656888B (en) | Chlorine dioxide producing unit and chlorine dioxide producing apparatus | |
| JP5688407B2 (en) | Chlorine dioxide generator | |
| TWI638767B (en) | Chlorne dioxide generating device and chlorine dioxide generating unit | |
| JP5845385B2 (en) | Air purifier | |
| TWI754614B (en) | Method for deactivating airborne microorganisms in space | |
| WO2011016206A1 (en) | Active substance generation method, active substance generation device, and air cleaner and humidifier each equipped with the device | |
| TW202340080A (en) | Chlorine dioxide generator | |
| JP6073694B2 (en) | Chlorine dioxide decomposition agent and decomposition method | |
| EP4324554A1 (en) | Photocatalyst, catalyst filter, catalyst module, and air purification system including the same | |
| JP5244406B2 (en) | Deodorizing composition |